Pest control agents

ABSTRACT

Disclosed is a composition for use as a pest control agent, comprising a compound represented by formula (I) or an agriculturally and horticulturally acceptable salt thereof as active ingredient and an agriculturally and horticulturally acceptable carrier:

BACKGROUND OF THE INVENTION

1. Field of Invention

The present invention relates to a composition for use as a pest control agent comprising a pyripyropene derivative as active ingredient.

2. Background Art

Pyripyropene A has inhibitory activity against ACAT (acyl-CoA: cholesterol acyltransferase) and is expected to be applied, for example, to the treatment of diseases induced by cholesterol accumulation, as described in Japanese Patent No. 2993767 (Japanese Patent Laid-Open Publication No. 360895/1992) and Journal of Antibiotics (1993), 46(7), 1168-9.

Further, pyripyropene analogues and derivatives and ACAT inhibitory activity thereof are described in Journal of Society of Synthetic Organic Chemistry, Japan (1998), Vol. 56, No. 6, pp. 478-488, WO 94/09417, Japanese Patent Laid-Open Publication No. 184158/1994, Japanese Patent Laid-Open Publication No. 239385/1996, Japanese Patent Laid-Open Publication No. 259569/1996, Japanese Patent Laid-Open Publication No. 269062/1996, Japanese Patent Laid-Open Publication No. 269063/1996, Japanese Patent Laid-Open Publication No. 269064/1996, Japanese Patent Laid-Open Publication No. 269065/1996, Japanese Patent Laid-Open Publication No. 269066/1996, Japanese Patent Laid-Open Publication No. 291164/1996, and Journal of Antibiotics (1997), 50(3), 229-36.

Furthermore, Applied and Environmental Microbiology (1996), 61(12), 4429-35 describes that pyripyropene A has insecticidal activity against larvae of Helicoverpa zea. Furthermore, WO 2004/060065 describes that pyripyropene A has insecticidal activity against Plutella xylostella L larvae and Tenebrio molitor L. In these documents, however, there is no specific description on insecticidal activity of pyripyropene A against other pests.

Further, none of the above documents describes insecticidal activity of pyripyropene analogues and derivatives.

Up to now, many compounds having insecticidal activity have been reported and have been used as pest control agents. However, the presence of insect species, which are resistant to or can be hardly controlled by these compounds, has posed a problem. Accordingly, the development of a novel pest control agent having excellent insectidal activity has still been desired.

SUMMARY OF THE INVENTION

The present inventors have now found that pyripyropene derivatives represented by formula (I) have significant insecticidal activity.

The present inventors further found that pyripyropene A and its derivatives represented by formula (Ia) have significant insecticidal activity against hemipteran pests.

Furthermore, the present inventors have found novel pyripyropene derivatives represented by formula (Ib) having significant insecticidal activity.

The present invention has been made based on such finding.

Accordingly, an object of the present invention is to provide a composition useful as a pest control agent, that comprises a pyripyropene derivative having significant insecticidal activity as active ingredient and can reliably exhibit the contemplated effect and can be used safely. Another object of the present invention is to provide a hemipteran pest control agent that comprises pyripyropene A and its derivative as active ingredient and can reliably exhibit the contemplated effect and can be used safely. A further object of the present invention is to provide a novel pyripyropene derivative having significant insecticidal activity.

According to one aspect of the present invention, there is provided a composition for use as a pest control agent, comprising a compound represented by formula (I) or an agriculturally and horticulturally acceptable salt thereof as active ingredient and an agriculturally and horticulturally acceptable carrier:

wherein

-   -   Het₁ represents optionally substituted 3-pyridyl,     -   R₁ represents hydroxy,         -   optionally substituted C₁₋₆ alkylcarbonyloxy,         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted C₂₋₆ alkynylcarbonyloxy,         -   optionally substituted C₁₋₆ alkyloxy,         -   optionally substituted C₂₋₆ alkenyloxy,         -   optionally substituted C₂₋₆ alkynyloxy,         -   optionally substituted benzyloxy, or         -   oxo in the absence of a hydrogen atom at the 13-position,         -   or     -   the bond between 5-position and 13-position represents a double         bond in the absence of R₁ and a hydrogen atom at the 5-position,         -   R₂ represents hydroxyl,         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy,         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted C₂₋₆ alkynylcarbonyloxy,         -   optionally substituted benzoyloxy, or         -   optionally substituted C₁₋₆ alkylsulfonyloxy,         -   R₃ represents a hydrogen atom,         -   hydroxyl,         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy,         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted C₂₋₆ alkynylcarbonyloxy,         -   optionally substituted benzoyloxy,         -   optionally substituted C₁₋₆ alkylsulfonyloxy,         -   optionally substituted benzenesulfonyloxy, or         -   optionally substituted five- or six-membered heterocyclic             thiocarbonyloxy, or     -   R₂ and R₃ together represent —O—CR₂′R₃—O— wherein R₂′ and R₃′,         which may be the same or different, represent a hydrogen atom,         C₁₋₆ alkyl, C₁₋₆ alkyloxy, C₂₋₆ alkenyl, optionally substituted         phenyl, or optionally substituted benzyl, or R₂′ and R₃′         together represent oxo or C₂₋₆ alkylene, and     -   R₄ represents a hydrogen atom,         -   hydroxyl;         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy,         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted C₂₋₆ alkynylcarbonyloxy,         -   optionally substituted benzoyloxy,         -   optionally substituted C₁₋₆ alkylsulfonyloxy,         -   optionally substituted benzenesulfonyloxy,         -   optionally substituted benzyloxy,         -   optionally substituted C₁₋₆ alkyloxy,         -   optionally substituted C₂₋₆ alkenyloxy,         -   optionally substituted C₂₋₆ alkynyloxy,         -   C₁₋₆ alkyloxy-C₁₋₆ alkyloxy,         -   C₁₋₆ alkylthio-C₁₋₆ alkyloxy,         -   C₁₋₆ alkyloxy-C₁₋₆ alkyloxy-C₁₋₆ alkyloxy,         -   optionally substituted C₁₋₆ alkyloxycarbonyloxy,         -   optionally substituted C₁₋₆ alkylamincoarbonyloxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic oxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic carbonyloxy,         -   optionally substituted thieno[3,2-b]pyridylcarbonyloxy,         -   optionally substituted 1H-indolylcarbonyloxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic thiocarbonyloxy, or         -   oxo in the absence of a hydrogen atom at the 7-position,         -   provided that         -   a compound wherein         -   Het₁ represents 3-pyridyl,         -   R₁ represents hydroxyl, and         -   all of R₂, R₃, and R₄ represent acetyloxy,             is excluded.

Further, according to another aspect of the present invention, there is provided a composition for use as a hemipteran pest control agent, comprising a compound represented by formula (Ia) or an agriculturally and horticulturally acceptable salt thereof as active ingredient and an agriculturally and horticulturally acceptable carrier:

wherein

-   -   Het₂ represents optionally substituted 3-pyridyl,     -   R₁₁ represents hydroxyl,         -   optionally substituted C₁₋₆ alkylcarbonyloxy,         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted C₂₋₆ alkynylcarbonyloxy,         -   optionally substituted C₁₋₆ alkyloxy,         -   optionally substituted C₂₋₆ alkenyloxy,         -   optionally substituted C₂₋₆ alkynyloxy,         -   optionally substituted benzyloxy, or         -   oxo in the absence of a hydrogen atom at the 13-position, or     -   the bond between 5-position and 13-position represents a double         bond in the absence of R₁₁ and a hydrogen atom at the         5-position,     -   R₁₂ represents hydroxyl,         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy,         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted C₂₋₆ alkynylcarbonyloxy,         -   optionally substituted benzoyloxy, or         -   optionally substituted C₁₋₆ alkylsulfonyloxy,     -   R₁₃ represents a hydrogen atom,         -   hydroxyl,         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy,         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted C₂₋₆ alkynylcarbonyloxy,         -   optionally substituted benzoyloxy,         -   optionally substituted C₁₋₆ alkylsulfonyloxy,         -   optionally substituted benzenesulfonyloxy, or         -   optionally substituted five- or six-membered heterocyclic             thiocarbonyloxy, or     -   R₁₂ and R₁₃ together represent —O—CR₁₂′R₁₃′—O— wherein R₁₂′ and         R₁₃′, which may be the same or different, represent a hydrogen         atom, C₁₋₆ alkyl, C₁₋₆ alkyloxy, C₂₋₆ alkenyl, optionally         substituted phenyl, or optionally substituted benzyl, or R₁₂′         and R₁₃′ together represent oxo or C₂₋₆ alkylene, and     -   R₁₄ represents a hydrogen atom,         -   hydroxyl,         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy,         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted C₂₋₆ alkynylcarbonyloxy,         -   optionally substituted benzoyloxy,         -   optionally substituted C₁₋₆ alkylsulfonyloxy,         -   optionally substituted benzenesulfonyloxy,         -   optionally substituted benzyloxy,         -   optionally substituted C₁₋₆ alkyloxy,         -   optionally substituted C₂₋₆ alkenyloxy,         -   optionally substituted C₂₋₆ alkynyloxy,         -   C₁₋₆ alkyloxy-C₁₋₆ alkyloxy,         -   C₁₋₆ alkylthio-C₁₋₆ alkyloxy,         -   C₁₋₆ alkyloxy-C₁₋₆ alkyloxy-C₁₋₆ alkyloxy,         -   optionally substituted C₁₋₆ alkyloxycarbonyloxy,         -   optionally substituted C₁₋₆ alkylaminocarbonyloxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic oxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic carbonyloxy,         -   optionally substituted thieno[3,2-b]pyridylcarbonyloxy,         -   optionally substituted 1H-indolylcarbonyloxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic thiocarbonyloxy, or         -   oxo in the absence of a hydrogen atom at the 7-position.

Further, the pyripyropene derivative according to the present invention comprises a compound represented by formula (Ib) or an agriculturally and horticulturally acceptable salt thereof:

wherein

-   -   Het₁ represents 3-pyridyl,     -   R₁ represents hydroxyl,     -   R₂ and R₃ represent propionyloxy or optionally substituted         cyclic C₃₋₆ alkylcarbonyloxy, and     -   R₄ represents hydroxyl,         -   optionally substituted cyclic C₃₋₆ alkylcarbonyloxy,         -   optionally substituted benzoyloxy, or         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic carbonyloxy.

The pyripyropene derivatives represented by formula (I) or formula (Ib) according to the present invention have excellent control effect against agricultural and horticultural pests, sanitary pests, parasites of animals, stored grain pests, clothing pests, and house pests and a compositions comprising the pyripyropene derivatives as active ingredient can be advantageously utilized as a novel pest control agent.

Further it is surprising that, among the compounds represented by formula (Ia), pyripyropene A has excellent control effect against hemipteran pests. Accordingly, a composition according to the present invention comprising the compounds represented by formula (Ia) including pyripyropene A, can be advantageously utilized particularly a hemipteran pest control agent.

DETAILED DESCRIPTION OF THE INVENTION

The term “halogen” as used herein means fluorine, chlorine, bromine, or iodine, preferably fluorine, chlorine, or bromine.

The terms “alkyl,” “alkenyl,” and “alkynyl” as used herein as a group or a part of a group respectively mean alkyl, alkenyl, and alkynyl that the group is of a straight chain, branched chain, or cyclic type or a type of a combination thereof unless otherwise specified. Further, for example, “C₁₋₆” in “C₁₋₆ alkyl” as used herein as a group or a part of a group means that the number of carbon atoms in the alkyl group is 1 to 6. Further, in the case of cyclic alkyl, the number of carbon atoms is at least three.

The term “heterocyclic ring” as used herein means a heterocyclic ring containing one or more, preferably one to four, heteroatoms, which may be the same or different, selected from the group consisting of nitrogen, oxygen, and sulfur atoms. Further, the expression “optionally substituted” alkyl as used herein means that one or more hydrogen atoms on the alkyl group may be substituted by one or more substituents which may be the same or different. It will be apparent to a person having ordinary skill in the art that the maximum number of substituents may be determined depending upon the number of substitutable hydrogen atoms on the alkyl group. This is true of functional groups other than the alkyl group.

3-Pyridyl represented by Het₁ and Het₂ is optionally substituted, and substituents include halogen atoms, C₁₋₄ alkyl, C₁₋₄ alkyloxy, nitro, cyano, formyl, trifluoromethyl, trifluoromethoxy, trifluoromethylthio, trifluoromethylsulfinyl, trifluoromethylsulfonyl, acetyl, and acetyloxy. Preferred are halogen atoms and trifluoromethyl. A chlorine atom and trifluoromethyl are more preferred.

“C₁₋₆ alkylcarbonyloxy” represented by R₁ and R₁₁ is optionally substituted, and substituents include halogen atoms, cyano, phenyl, trifluoromethoxy, and trifluoromethylthio.

“C₁₋₁₈ alkylcarbonyloxy” represented by R₂, R₃ and R₄, and R₁₂, R₁₃ and R₁₄ is preferably C₁₋₆ alkylcarbonyloxy, more preferably propionyloxy or cyclic C₃₋₆ alkylcarbonyloxy. The alkylcarbonyloxy group is optionally substituted, and substituents include halogen atoms, cyano, cyclic C₃₋₆alkyl, phenyl, trifluoromethoxy, trifluoromethylthio, pyridyl, and pyridylthio. More preferred are halogen atoms, cyclic C₃₋₆ alkyl, and pyridyl.

“C₂₋₆ alkenylcarbonyloxy” represented by R₁, R₂, R₃ and R₄, and R₁₁, R₁₂, R₁₃ and R₁₄ is optionally substituted, and substituents include halogen atoms, cyano, phenyl, trifluoromethoxy, and trifluoromethylthio.

“C₂₋₆ alkynylcarbonyloxy” represented by R₁, R₂, R₃ and R₄, and R₁₁, R₁₂, R₁₃ and R₁₄ is optionally substituted, and substituents include halogen atoms, cyano, phenyl, trifluoromethoxy, and trifluoromethylthio.

“C₁₋₆ alkyloxy” represented by R₁ and R₄, and R₁₁ and R₁₄ is optionally substituted, and substituents include halogen atoms; cyano; phenyl; trifluoromethoxy; trifluoromethylthio; C₁₋₆ alkylcarbonyl optionally substituted by a halogen atom; and C₁₋₆ alkylcarbonyloxy optionally substituted by a halogen atom.

“C₂₋₆ alkenyloxy” represented by R₁ and R₄, and R₁₁ and R₁₄ is optionally substituted, and substituents include halogen atoms; cyano; phenyl; trifluoromethoxy; trifluoromethylthio; C₁₋₆ alkylcarbonyl optionally substituted by a halogen atom; and C₁₋₆ alkylcarbonyloxy optionally substituted by a halogen atom.

“C₂₋₆ alkynyloxy” represented by R₁ and R₄, and R₁₁ and R₁₄ is optionally substituted, and substituents include halogen atoms; cyano; phenyl; trifluoromethoxy; trifluoromethylthio; C₁₋₆ alkylcarbonyl optionally substituted by a halogen atom; and C₁₋₆ alkylcarbonyloxy optionally substituted by a halogen atom.

Phenyl in “benzyloxy” represented by R₁ and R₄, and R₁₁ and R₁₄ is optionally substituted, and substituents include halogen atoms; C₁₋₆ alkyloxy optionally substituted by a halogen atom: C₁₋₆ alkyl optionally substituted by a halogen atom; C₁₋₆ alkylcarbonyl optionally substituted by a halogen atom; C₁₋₆ alkylcarbonyloxy optionally substituted by a halogen atom; C₁₋₆ alkylcarbonylamino optionally substituted by a halogen atom; C₁₋₆ alkylaminocarbonyloxy optionally substituted by a halogen atom; C₁₋₆ alkylaminocarbonyl optionally substituted by a halogen atom; C₁₋₆ alkylsulfonyloxy optionally substituted by a halogen atom; C₁₋₆ alkylthio optionally substituted by a halogen atom; C₁₋₆ alkylsulfinyl optionally substituted by a halogen atom; C₁₋₆ alkylsulfonyl optionally substituted by a halogen atom, cyano; formyl; azide; guanidyl; group —C(═NH)—NH₂; and group —CH═N—O—CH₃.

Phenyl in “benzoyloxy” represented by R₂, R₃ and R₄, and R₁₂, R₁₃ and R₁₄ is optionally substituted, and substituents include halogen atoms; C₁₋₆ alkyloxy optionally substituted by a halogen atom; C₁₋₆ alkyl optionally substituted by a halogen atom; C₁₋₆ alkylcarbonyl optionally substituted by a halogen atom; C₁₋₆ alkylcarbonyloxy optionally substituted by a halogen atom; C₁₋₆ alkylcarbonylamino optionally substituted by a halogen atom; C₁₋₆ alkylaminocarbonyloxy optionally substituted by a halogen atom; C₁₋₆ alkylaminocarbonyl optionally substituted by a halogen atom; C₁₋₆ alkylsulfonyloxy optionally substituted by a halogen atom; C₁₋₆ alkylthio optionally substituted by a halogen atom; C₁₋₆ alkylsulfinyl optionally substituted by a halogen atom; C₁₋₆ alkylsulfonyl optionally substituted by a halogen atom; cyano; nitro; formyl; azide, guanidyl; group —C(═NH)—NH₂; and group —CH═N—O—CH₃. Preferred are halogen atoms, C₁₋₆ alkyl substituted by a halogen atom, cyano, and nitro.

Phenyl in “benzenesulfonyloxy” represented by R₃ and R₄, and R₁₃ and R₁₄ is optionally substituted, and substituents include halogen atoms; C₁₋₆ alkyloxy optionally substituted by a halogen atom; C₁₋₆ alkyl optionally substituted by a halogen atom; C₁₋₆ alkylcarbonyl optionally substituted by a halogen atom; C₁₋₆ alkylcarbonyloxy optionally substituted by a halogen atom; C₁₋₆ alkylcarbonylamino optionally substituted by a halogen atom; C₁₋₆ alkylaminocarbonyloxy optionally substituted by a halogen atom; C₁₋₆ alkylaminocarbonyl optionally substituted by a halogen atom; C₁₋₆ alkylsulfonyloxy optionally substituted by a halogen atom: C₁₋₆ alkylthio optionally substituted by a halogen atom; C₁₋₆ alkylsulfinyl optionally substituted by a halogen atom; C₁₋₆ alkylsulfonyl optionally substituted by a halogen atom; cyano; formyl; azide; guanidyl; group —C(═NH)—NH₂; and group —CH═H—O—CH₃.

“C₁₋₆ alkylsulfonyloxy” represented by R₂, R₃ and R₄, and R₁₂, R₁₃ and R₁₄ is optionally substituted, and substituents include halogen atoms, cyano, phenyl, trifluoromethoxy, and trifluoromethylthio.

“C₁₋₆ alkyloxycarbonyloxy” represented by R₄ and R₁₄ is optionally substituted, and substituents include halogen atoms, cyano, phenyl, trifluoromethoxy, and trifluoromethylthio.

“C₁₋₆ alkylaminocarbonyloxy” represented by R₄ and R₁₄ is optionally substituted, and substituents include halogen atoms, cyano, phenyl, trifluoromethoxy, and trifluoromethylthio.

“Phenyl” represented by R₂′ and R₃′, and R₁₂′ and R₁₃′ and phenyl in “benzyl” represented by R₂′ and R₃′, and R₁₂′ and R₁₃′ is optionally substituted, and substituents include halogen atoms, C₁₋₄ alkyl, C₁₋₄ alkyloxy, nitro, cyano, formyl, trifluoromethoxy, acetyl, and acetyloxy.

“Saturated or unsaturated five- or six-membered heterocyclic ring” in “saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy” represented by R₃ and R₁₃, and “saturated or unsaturated five- or six-membered heterocyclic oxy,” “saturated or unsaturated five- or six-membered heterocyclic carbonyloxy,” and “saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy” represented by R₄ and R₁₄, is preferably, saturated or unsaturated five- or six-membered heterocyclic ring containing one to three heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur atoms, more preferably, saturated or unsaturated five- or six-membered heterocyclic ring containing one or two heteroatoms selected from the group consisting of nitrogen, oxygen, and sulfur atoms, more preferably, saturated or unsaturated five- or six-membered heterocyclic ring containing one or two nitrogen atoms, saturated or unsaturated five- or six-membered heterocyclic ring containing one or two oxygen atoms, saturated or unsaturated five- or six-membered heterocyclic ring containing one or two sulfur atoms, saturated or unsaturated five- or six-membered heterocyclic ring containing one nitrogen atom and one oxygen atom, or saturated or unsaturated five- or six-membered heterocyclic ring containing one nitrogen atom and one sulfur atom.

More specifically, examples of the “saturated or unsaturated five- or six-membered heterocyclic ring” include thienyl, furyl, pyrrolyl, imidazolyl, pyrazolyl, isothiazoyl, isoxazolyl, thiazolyl, oxazolyl, pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, tetrahydropyranyl, piperidinyl, piperazinyl, morpholinyl, and mannosyl. Preferred are pyridyl, furanyl, thiazolyl, imidazolyl, tetrahydropyranyl, and mannosyl. More specific examples thereof include (2- or 3-) thienyl, (2- or 3-)furyl, (1-, 2- or 3-)pyrrolyl, (1-, 2-, 4- or 5-)imidazolyl, (1-, 3-, 4- or 5-) pyrazolyl, (3-, 4- or 5-)isothiazoyl, (3-, 4- or 5-)isoxazolyl, (2-, 4- or 5-)thiazolyl, (2-, 4- or 5-) oxazolyl, (2-, 3- or 4)pyridyl- or, (2-, 4-, 5- or 6-)pyrimidinyl, (2- or 3-)pyrazinyl, (3- or 4-) pyridazinyl, (2-, 3- or 4-)tetrahydropyranyl, (1-, 2-, 3- or 4-)piperidinyl, (1-, 2- or 3-) piperazinyl, and (2-, 3- or 4-)morpholinyl, preferably 3-pyridyl, 2-franyl, 5-thiazolyl, 1-imidazolyl, 5-imidazolyl, and 2-tetrahydropyranyl, more preferably 2-tetrahydropyranyl, 2-pyrazinyl, and 3-pyridyl, particularly preferably 3-pyridyl.

The heterocyclic ring in the “saturated or unsaturated five- or six-membered heterocyclic carbonyloxy” and “saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy” and “thieno[3,2-b]pyridylcarbonyloxy” and “1H-indolylcarbonyloxy” represented by R₄ and R₁₄ are optionally substituted, and substituents include halogen atoms, C₁₋₄ alkyl, C₁₋₄ alkyloxy, C₁₋₄ alkylthio, nitro, cyano, formyl, trifluoromethoxy, trifluoromethyl, trifluoromethylthio, trifluoromethylsulfinyl, trifluoromethylsulfonyl, acetyl, acetyloxy, benzoyl, and C₁₋₄ alkyloxycarbonyl. Preferred are halogen atoms, C₁₋₄ alkyl, C₁₋₄ alkyloxy and trifluoromethyl.

The heterocyclic ring in the “saturated or unsaturated five- or six-membered heterocyclic oxy” is optionally substituted, and substituents include hydroxyl, benzyloxy, a halogen atom, C₁₋₄ alkyl, C₁₋₄ alkyloxy, nitro, cyano, formyl, trifluoromethoxy, trifluoromethyl, trifluoromethylthio, trifluoromethylsulfinyl, trifluoromethylsulfonyl, acetyl, and acetyloxy. Preferred are hydroxyl and benzyloxy.

A Composition for Use as a Pest Control Agent, Comprising a Compound Represented by Formula (I)

According to a preferred embodiment of the present invention, in the compound represented by formula (I), preferably, Het₁ represents 3-pyridyl.

Further, according to a preferred embodiment of the present invention, in the compound represented by formula (I), R₁ represents hydroxyl, C₁₋₅ alkylcarbonyloxy, C₁₋₃ alkyloxy, or benzyloxy, or oxo in the absence of a hydrogen atom at the 13-position, or the bond between 5-position and 13-position represents a double bond in the absence of R₁ and a hydrogen atom at the 5-position. More preferably, R₁ represents hydroxyl or C₁₋₆ alkylcarbonyloxy, or the bond between 5-position and 13-position represents a double bond in the absence of R₁ and a hydrogen atom at the 5-position, still more preferably R₁ represents hydroxyl.

According to a preferred embodiment of the present invention, in the compound represented by formula (I), R₂ represents hydroxyl, optionally substituted C₁₋₁₈ alkylcarbonyloxy, optionally substituted benzoyloxy, or C₁₋₃ alkylsulfonyloxy, more preferably optionally substituted C₁₋₁₈ alkylcarbonyloxy, still more preferably optionally substituted C₁₋₆ alkylcarbonyloxy, still more preferably straight chain or branched chain C₁₋₆ alkylcarbonyloxy (particularly propionyloxy) or optionally substituted cyclic C₃₋₆ alkylcarbonyloxy.

In a preferred embodiment of the present invention, in the compound represented by formula (I), R₃ represents a hydrogen atom, hydroxyl, optionally substituted C₁₋₁₈ alkylcarbonyloxy, optionally substituted benzoyloxy, C₁₋₆ alkylsulfonyloxy, optionally substituted benzenesulfonyloxy, or saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy, more preferably optionally substituted C₁₋₆ alkylcarbonyloxy or C₁₋₆ alkylsulfonyloxy, still more preferably optionally substituted C₁₋₆ alkylcarbonyloxy, still more preferably straight chain or branched chain C₂₋₄ alkylcarbonyloxy (particularly propionyloxy) or optionally substituted cyclic C₃₋₆ alkylcarbonyloxy.

According to a preferred embodiment of the present invention, in the compound represented by formula (I), R₂ and R₃ together represent —O—CR₂′R₃′—O—, wherein R₂′ and R₃′, which may be the same or different, represent a hydrogen atom, C₁₋₆ alkyl, C₁₋₃ alkyloxy, C₂₋₃ alkenyl, benzyl, or optionally substituted phenyl, or R₂′ and R₃′ together represent oxo or C₂₋₆ alkylene. More preferably, R₂ and R₃ together represent —O—CR₂′R₃′—O—, wherein R₂′ and R₃′, which may be the same or different, represent a hydrogen atom, C₁₋₆ alkyl, or optionally substituted phenyl, or R₂′ and R₃′ together represent oxo or C₂₋₆ alkylene.

According to a preferred embodiment of the present invention, in the compound represented by formula (I), R₄ represents a hydrogen atom, hydroxyl, optionally substituted C₁₋₁₈ alkylcarbonyloxy, C₂₋₆ alkenylcarbonyloxy, C₂₋₆ alkynyl carbonyloxy, C₁₋₆ alkylsulfonyloxy, benzenesulfonyloxy, benzyloxy, C₁₋₃ alkyloxy, C₁₋₃ alkyloxy-C₁₋₃ alkyloxy, C₁₋₃ alkylthio-C₁₋₃ alkyloxy, C₁₋₃ alkyloxy-C₁₋₃ alkyloxy-C₁₋₃ alkyloxy, optionally substituted C₁₋₃ alkyloxycarbonyloxy, optionally substituted C₁₋₆ alkylaminocarbonyloxy, optionally substituted benzoyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, optionally substituted thieno[3,2-b]pyridylcarbonyloxy, optionally substituted 1H-indolylcarbonyloxy, or saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy, or oxo in the absence of a hydrogen atom at the 7-position, More preferably, R₄ represents hydroxyl, optionally substituted C₁₋₆ alkylcarbonyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted benzoyloxy, C₁₋₃ alkyloxy-C₁₋₃ alkyloxy, optionally substituted C₁₋₆ alkylaminocarbonyloxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy optionally substituted thieno[3,2-b]pyridylcarbonyloxy, optionally substituted 1H-indolylcarbonyloxy, or saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy, or oxo in the absence of a hydrogen atom at the 7-position. Still more preferably, R₄ represents hydroxyl, optionally substituted C₁₋₆ alkylcarbonyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted benzoyloxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, or saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy. Still more preferably, R₄ represents hydroxyl, straight chain or branched chain C₂₋₄ alkylcarbonyloxy (particularly propionyloxy), optionally substituted cyclic C₃₋₆ alkylcarbonyloxy, or optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy.

According to another preferred embodiment of the present invention, in the compound represented by formula (I), Het₁ represents 3-pyridyl, R₁ represents hydroxyl or C₁₋₆ alkylcarbonyloxy, or the bond between 5-position and 13-position represents a double bond in the absence of R₁ and a hydrogen atom at the 5-position, R₂ represents optionally substituted C₁₋₆ alkylcarbonyloxy, R₃ represents optionally substituted C₁₋₆ alkylcarbonyloxy or C₁₋₆ alkylsulfonyloxy, or R₂ and R₃ together represent —O—CR₂′R₃′—O— wherein R₂′ and R₃′, which may be the same or different, represent a hydrogen atom, C₁₋₆ alkyl, or optionally substituted phenyl, or R₂′ and R₃′ together represent oxo or C₂₋₆ alkylene, and R₄ represents hydroxyl, optionally substituted C₁₋₆ alkylcarbonyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted benzoyloxy, C₁₋₃ alkyloxy-C₁₋₃ alkyloxy, optionally substituted C₁₋₆ alkylaminocarbonyloxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, optionally substituted thieno[3,2-b]pyridylcarbonyloxy, optionally substituted 1H-indolylcarbonyloxy, saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy, or oxo in the absence of a hydrogen atom at the 7-position.

According to another preferred embodiment of the present invention, in the compound represented by formula (I), Het₁ represents 3-pyridyl, R₁ represents hydroxyl, R₂ represents optionally substituted C₁₋₆ alkylcarbonyloxy, and R₃ represents optionally substituted C₁₋₆ alkylcarbonyloxy or C₁₋₆ alkylsulfonyloxy, and R₄ represents hydroxyl, optionally substituted C₁₋₆ alkylcarbonyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted benzoyloxy, C₁₋₃ alkyloxy-C₁₋₃ alkyloxy, optionally substituted C₁₋₆ alkylaminocarbonyloxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, optionally substituted thieno[3,2-b]pyridylcarbonyloxy, optionally substituted 1H-indolylcarbonyloxy, saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy, or oxo in the absence of a hydrogen atom at the 7-position.

According to another preferred embodiment of the present invention, in the compound represented by formula (I), Het₁ represents 3-pyridyl, R₁ represents hydroxyl, R₂ represents optionally substituted C₁₋₆ alkylcarbonyloxy, R₃ represents optionally substituted C₁₋₆ alkylcarbonyloxy or C₁₋₆ alkylsulfonyloxy, and R₄ represents hydroxyl, optionally substituted C₁₋₆ alkylcarbonyloxy, optionally substituted benzoyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, or saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy.

According to another preferred embodiment of the present invention, in the compound represented by formula (I), Het₁ represents 3-pyridyl, R₁ represents hydroxyl, and R₂ and R₃ represent optionally substituted cyclic C₃₋₆ alkylcarbonyloxy.

According to another preferred embodiment of the present invention, in the compound represented by formula (I),

-   -   Het₁ represents 3-pyridyl,     -   R₁ represents hydroxyl or         -   optionally substituted C₁₋₆ alkylcarbonyloxy or     -   the bond between 5-position and 13-position represents a double         bond in the absence of R₁ and a hydrogen atom at the 5-position,     -   R₂ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy or         -   optionally substituted benzoyloxy,     -   R₃ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy or         -   optionally substituted C₁₋₆ alkylsulfonyloxy, and     -   R₄ represents hydroxyl,         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy,         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted benzoyloxy,         -   optionally substituted C₁₋₆ alkylaminocarbonyloxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic oxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic carbonyloxy,         -   optionally substituted thieno[3,2-b]pyridylcarbonyloxy         -   optionally substituted 1H-indolylcarbonyloxy, or         -   oxo in the absence of a hydrogen atom at the 7-position.

According to another preferred embodiment of the present invention, in the compound represented by formula (I),

-   -   Het₁ represents 3-pyridyl,     -   R₁ represents hydroxyl or         -   optionally substituted C₁₋₆ alkylcarbonyloxy, or     -   the bond between 5-position and 13-position represents a double         bond in the absence of R1 and a hydrogen atom at the 5-position,     -   R₂ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy,     -   R₃ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy or         -   optionally substituted C₁₋₆ alkylsulfonyloxy, and     -   R₄ represents hydroxyl,         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy,         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted benzoyloxy,         -   optionally substituted C₁₋₆ alkylaminocarbonyloxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic oxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic carbonyloxy, or         -   oxo in the absence of a hydrogen atom at the 7-position.

According to another preferred embodiment of the present invention, in the compound represented by formula (I),

-   -   Het₁ represents 3-pyridyl,     -   R₁ represents hydroxyl or         -   optionally substituted C₁₋₆ alkylcarbonyloxy, or     -   the bond between 5-position and 13-position represents a double         bond in the absence of R₁ and a hydrogen atom at the 5-position,     -   R₂ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy,     -   R₃ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy,     -   R₄ represents hydroxyl,         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy,         -   optionally substituted benzoyloxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic oxy, or         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic carbonyloxy.

According to another preferred embodiment of the present invention, In the compound represented by formula (I), Het₁ represents 3-pyridyl, R₁ represents hydroxyl, R₂ represents C₁₋₆ alkylcarbonyloxy, and R₃ and/or R₄ represent C₂₋₄ alkylcarbonyloxy.

Further, an agriculturally and horticulturally acceptable salt of the compound represented by formula (I) include the same as that of the compound represented by formula (Ib) described below.

A Composition for Use as a Hemipteran Pest Control Agent, Comprising a Compound Represented by Formula (Ia)

According to a preferred embodiment of the present invention, in the compound represented by formula (Ia), preferably, Het₂ represents 3-pyridyl.

Further, according to a preferred embodiment of the present invention, in the compound represented by formula (Ia), R₁₁ represents hydroxyl, C₁₀₆ alkylcarbonyloxy, C₁₋₃ alkyloxy, or benzyloxy, or oxo in the absence of a hydrogen atom at the 13-position, or the bond between 5-position and 13-position represents a double bond in the absence of R₁₁ and a hydrogen atom at the 5-position. More preferably, R₁₁ represents hydroxyl or C₁₋₆ alkylcarbonyloxy, or the bond between 5-position and 13-position represents a double bond in the absence of R₁₁ and a hydrogen atom at the 5-position, still more preferably R₁₁ represents hydroxyl.

According to a preferred embodiment of the present invention, in the compound represented by formula (Ia), R₁₂ represents hydroxyl, optionally substituted C₁₋₁₈ alkylcarbonyloxy, optionally substituted benzoyloxy, or C₁₋₃ alkylsulfonyloxy, more preferably optionally substituted C₁₋₁₈ alkylcarbonyloxy, still more preferably optionally substituted C₁₋₆ alkylcarbonyloxy, still more preferably straight chain or branched chain C₁₋₆ alkylcarbonyloxy (particularly propionyloxy) or optionally substituted cyclic C₃₋₆ alkylcarbonyloxy.

In a preferred embodiment of the present invention, in the compound represented by formula (Ia), R₁₃ represents a hydrogen atom, hydroxyl, optionally substituted C₁₋₁₈ alkylcarbonyloxy, optionally substituted benzoyloxy, C₁₋₆ alkylsulfonyloxy, optionally substituted benzenesulfonyloxy, or saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy more preferably optionally substituted C₁₋₆ alkylcarbonyloxy or C₁₋₆ alkylsulfonyloxy, still more preferably optionally substituted C₁₋₆ alkylcarbonyloxy, still more preferably straight chain or branched chain C₂₋₄ alkylcarbonyloxy (particularly propionyloxy) or optionally substituted cyclic C₃₋₆ alkylcarbonyloxy.

According to a preferred embodiment of the present invention, in the compound represented by formula (Ia), R₁₂ and R₁₃ together represent —O—CR₁₂′R₁₃′—O—, wherein R₁₂′ and R₁₃′, which may be the same or different, represent a hydrogen atom, C₁₋₆ alkyl, C₁₋₃ alkyloxy, C₂₋₃ alkenyl, benzyl, or optionally substituted phenyl, or R₁₂′ and R₁₃′ together represent oxo or C₂₋₆ alkylene. More preferably, R₁₂ and R₁₃ together represent —O—CR₁₂′R₁₃′—O—, wherein R₁₂′ and R₁₃′, which may be the same or different, represent a hydrogen atom, C₁₋₆ alkyl, or optionally substituted phenyl, or R₁₂′ and R₁₃′ together represent oxo or C₂₋₆ alkylene.

According to a preferred embodiment of the present invention, in the compound represented by formula (Ia), R₁₄ represents a hydrogen atom, hydroxyl, optionally substituted C₁₋₁₈ alkylcarbonyloxy, C₂₋₆ alkenylcarbonyloxy, C₂₋₆ alkynyl carbonyloxy, C₁₋₃ alkylsulfonyloxy, benzenesulfonyloxy, benzyloxy, C₁₋₃ alkyloxy, C₁₋₃ alkyloxy-C₁₋₃ alkyloxy, C₁₋₃ alkylthio-C₁₋₃ alkyloxy, C₁₋₃ alkyloxy-C₁₋₃ alkyloxy-C₁₋₃ alkyloxy, optionally substituted C₁₋₃ alkyloxycarbonyloxy, optionally substituted C₁₋₆ alkylaminocarbonyloxy, optionally substituted benzoyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, optionally substituted thieno[3,2-b]pyridylcarbonyloxy, optionally substituted 1H-indolylcarbonyloxy, or saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy, or oxo in the absence of a hydrogen atom at the 7-position. More preferably, R₁₄ represents hydroxyl, optionally substituted C₁₋₆ alkylcarbonyloxy, optionally substituted benzoyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, C₁₋₃ alkyloxy-C₁₋₃ alkyloxy, optionally substituted C₁₋₆ alkylaminocarbonyloxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, optionally substituted thieno[3,2-b]pyridylcarbonyloxy, optionally substituted 1H-indolylcarbonyloxy, or saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy, or oxo in the absence of a hydrogen atom at the 7-position. Still more preferably, R₁₄ represents hydroxyl, optionally substituted C₁₋₆ alkylcarbonyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted benzoyloxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, or saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy. Still more preferably, R₁₄ represents straight chain or branched chain C₂₋₄ alkylcarbonyloxy (particularly propionyloxy), optionally substituted cyclic C₃₋₆ alkylcarbonyloxy, or optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy.

According to another preferred embodiment of the present invention, in the compound represented by formula (Ia), Het₂ represents 3-pyridyl, R₁₁ represents hydroxyl or C₁₋₆ alkylcarbonyloxy, or the bond between 5-position and 13-position represents a double bond in the absence of R₁₁ and a hydrogen atom at the 5-position, R₁₂ represents optionally substituted C₁₋₆ alkylcarbonyloxy, R₁₃ represents optionally substituted C₁₋₆ alkylcarbonyloxy or C₁₋₆ alkylsulfonyloxy, or R₁₂ and R₁₃ together represent —O—CR₁₂′R₁₃′—O— wherein R₁₂′ and R₁₃′, which may be the same or different, represent a hydrogen atom, C₁₋₆ alkyl, or optionally substituted phenyl, or R₁₂′ and R₁₃′ together represent oxo or C₂₋₆ alkylene, and R₁₄ represents hydroxyl, optionally substituted C₁₋₆ alkylcarbonyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted benzoyloxy, C₁₋₃ alkyloxy-C₁₋₃ alkyloxy, optionally substituted C₁₋₆ alkylaminocarbonyloxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, optionally substituted thieno[3,2-b]pyridylcarbonyloxy, optionally substituted 1H-indolylcarbonyloxy, saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy, or oxo in the absence of a hydrogen atom at the 7-position.

According to another preferred embodiment of the present invention, in the compound represented by formula (Ia), Het₂ represents 3-pyridyl, R₁₁ represents hydroxyl, R₁₂ represents optionally substituted C₁₋₆ alkylcarbonyloxy, and R₁₃ represents optionally substituted C₁₋₆ alkylcarbonyloxy or C₁₋₆ alkylsulfonyloxy, and R₁₄ represents hydroxyl, optionally substituted C₁₋₆ alkylcarbonyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted benzoyloxy, C₁₋₃ alkyloxy-C₁₋₃ alkyloxy, optionally substituted C₁₋₆ alkylaminocarbonyloxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, optionally substituted thieno[3,2-b]pyridylcarbonyloxy, optionally substituted 1H-indolylcarbonyloxy, saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy, or oxo in the absence of a hydrogen atom at the 7-position.

According to another preferred embodiment of the present invention, in the compound represented by formula (Ia), Het₂ represents 3-pyridyl, R₁₁ represents hydroxyl, R₁₂ represents optionally substituted C₁₋₆ alkylcarbonyloxy, R₁₃ represents optionally substituted C₁₋₆ alkylcarbonyloxy or C₁₋₆ alkylsulfonyloxy, and R₁₄ represents hydroxyl, optionally substituted C₁₋₆ alkylcarbonyloxy, optionally substituted benzoyloxy, saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, or saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy.

According to another preferred embodiment of the present invention, in the compound represented by formula (Ia), Het₂ represents 3-pyridyl, R₁₁ represents hydroxyl, and R₁₂ and R₁₃ represent optionally substituted cyclic C₃₋₆ alkylcarbonyloxy,

According to another preferred embodiment of the present invention, in the compound represented by formula (Ia),

-   -   Het₂ represents 3-pyridyl,     -   R₁₁ represents hydroxyl or         -   optionally substituted C₁₋₆ alkylcarbonyloxy, or     -   the bond between 5-position and 13-position represents a double         bond in the absence of R₁₁ and a hydrogen atom at the         5-position,     -   R₁₂ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy or         -   optionally substituted benzoyloxy,     -   R₁₃ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy or         -   optionally substituted C₁₋₆ alkylsulfonyloxy, and     -   R₁₄ represents hydroxyl,         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy.         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted benzoyloxy,         -   optionally substituted C₁₋₆ alkylaminocarbonyloxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic oxy.         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic carbonyloxy,         -   optionally substituted thieno[3,2-b]pyridylcarbonyloxy,         -   optionally substituted 1H-indolylcarbonyloxy, or         -   oxo in the absence of a hydrogen atom at the 7-position,

According to another preferred embodiment of the present invention, in the compound represented by formula (Ia),

-   -   Het₂ represents 3-pyridyl,     -   R₁₁ represents hydroxyl or         -   optionally substituted C₁₋₆ alkylcarbonyloxy, or     -   the bond between 5-position and 13-position represents a double         bond in the absence of R₁₁ and a hydrogen atom at the         5-position,     -   R₁₂ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy,     -   R₁₃ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy or         -   optionally substituted C₁₋₆ alkylsulfonyloxy, and     -   R₁₄ represents hydroxyl,         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy,         -   optionally substituted C₂₋₆ alkenylcarbonyloxy,         -   optionally substituted benzoyloxy,         -   optionally substituted C₁₋₆ alkylaminocarbonyloxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic oxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic carbonyloxy, or         -   oxo in the absence of a hydrogen atom at the 7-position,

According to another preferred embodiment of the present invention, in the compound represented by formula (Ia), Het₂ represents 3-pyridyl,

-   -   R₁₁ represents hydroxyl or         -   optionally substituted C₁₋₆ alkylcarbonyloxy, or     -   the bond between 5-position and 13-position represents a double         bond in the absence of R₁₁ and a hydrogen atom at the         5-position,     -   R₁₂ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy,     -   R₁₃ represents optionally substituted C₁₋₁₈ alkylcarbonyloxy,     -   R₁₄ represents hydroxyl,         -   optionally substituted C₁₋₁₈ alkylcarbonyloxy,         -   optionally substituted benzoyloxy,         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic oxy, or         -   optionally substituted saturated or unsaturated five- or             six-membered heterocyclic carbonyloxy.

According to another preferred embodiment of the present invention, in the compound represented by formula (Ia), Het₂ represents 3-pyridyl, R₁₁ represents hydroxyl, R₁₂ represents C₁₋₆ alkylcarbonyloxy, and R₁₃ and/or R₁₄ represent C₂₋₄ alkylcarbonyloxy,

Further, an agriculturally and horticulturally acceptable salt of the compound represented by formula (Ia) include the same as that of the compound represented by formula (Ib) described below.

Compounds of Formula (Ib) or its Agriculturally and Horticulturally Acceptable Salts

Compounds of formula (Ib) are novel pyripyropene derivatives that are comprised as a part in the compound represented by formula (I). In particular, they have significant insecticidal activity.

According to an embodiment of the present invention, there is provided the compounds of formula (Ib), excluding a compound wherein Het₁ represents 3-pyridyl, R₁ represents hydroxyl, and R₂ and R₃ represent propionyloxy, and R₄ represents hydroxyl.

According to another preferred embodiment of the present invention, in the compound represented by formula (Ib), R₂ and R₃ represent optionally substituted cyclic C₃₋₆ alkylcarbonyloxy, R₄ represents hydroxyl, optionally substituted cyclic C₃₋₆ alkylcarbonyloxy, or optionally substituted benzoyloxy. Alternatively, R₂ and R₃ represent propionyloxy, R₄ represents optionally substituted cyclic C₃₋₆ alkylcarbonyloxy, or optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy.

According to another preferred embodiment of the present invention, in the compounds represented by formula (Ib), R₂ and R₃ represent optionally substituted cyclic C₃₋₆ alkylcarbonyloxy, R₄ represents hydroxyl, optionally substituted cyclic C₃₋₆ alkylcarbonyloxy, or optionally substituted benzoyloxy.

According to another preferred embodiment of the present invention, in the compounds represented by formula (Ib), R₂ and R₃ represent propionyloxy, R₄ represents optionally substituted cyclic C₃₋₆ alkylcarbonyloxy or optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy.

According to still another preferred embodiment of the present invention, there is provided a pest control agent comprising a compound represented by formula (Ib) or an agriculturally and horticulturally acceptable salt thereof as an active ingredient.

Agriculturally and horticulturally acceptable salts in the compounds of formula (Ib) include, for example, acid addition salts such as hydrochlorides, nitrates, sulfates, phosphates, or acetates.

Specific examples of the compounds represented by formula (I), (Ia), or (Ib) include compounds shown in Tables 1 to 14 below. In the following tables, H(═) means that the bond between 5-position and 13-position represents a double bond in the absence of R₁ and a hydrogen atom at the 5-position

TABLE 1 Compound No. R₁ R₂ R₃ R₄ Het₁ 1 OH OCOCH₃ OCOCH₃ OCOCH₂CH₃ 3-pyridyl 2 OH OCOCH₃ OCOCH₃ OCOCH₃CF₂ 3-pyridyl 3 OH OCOCH₃ OCOCH₃ OCOCH₂OCH₃ 3-pyridyl 4 OH OCOCH₃ OCOCH₃ OCOCH₂OCOCH₃ 3-pyridyl 5 OH OCOCH₃ OCOCH₃ OCOCH₂CH₂CN 3-pyridyl 6 OH OCOCH₃ OCOCH₃ OCO(CH₂)₂CH₃ 3-pyridyl 7 OH OCOCH₃ OCOCH₃ OCO(CH₂)₃CH₃ 3-pyridyl 8 OH OCOCH₃ OCOCH₃ OCO(CH₂)₄CH₃ 3-pyridyl 9 OH OCOCH₃ OCOCH₃ OCO(CH₂)₅CH₃ 3-pyridyl 10 OH OCOCH₃ OCOCH₃ OCO(CH₂)₆CH₃ 3-pyridyl 11 OH OCOCH₃ OCOCH₃ OCO(CH₂)₁₆CH₃ 3-pyridyl 12 OH OCOCH₃ OCOCH₃ OCOCH(CH₃)₂ 3-pyridyl 13 OH OCOCH₃ OCOCH₃ OCOCH(C₃)₂ 3-pyridyl 14 OH OCOCH₃ OCOCH₃ OCOCH₂CH(CH₃)₂ 3-pyridyl 15 OH OCOCH₃ OCOCH₃ OCO(CH₂)₂CH(CH₃)₂ 3-pyridyl 16 OH OCOCH₃ OCOCH₃ OCO-trans- 3-pyridyl CH═CHCH₂CH₃ 17 OH OCOCH₃ OCOCH₃ OCOCH₂C≡OCH₃ 3-pyridyl 18 OH OCOCH₃ OCOCH₃ OCOC≡CCH₂CH₃ 3-pyridyl 19 OH OCOCH₃ OCOCH₃ OCO(CH₃)₂C≡CH 3-pyridyl 20 OH OCOCH₃ OCOCH₃ OCO(CH₂)₃CH═CH₂ 3-pyridyl

TABLE 2 Compound No. R₁ R₂ R₃ R₄ Het₁ 21 OH OCOCH₃ OCOCH₃ OCOCH₂C₆H₅ 3-pyridyl 22 OH OCOCH₃ OCOCH₃ OCO(CH₂)₂C₆H₅ 3-pyridyl 23 OH OCOCH₃ OCOCH₃ OCOC₆H₅ 3-pyridyl 24 OH OCOCH₃ OCOCH₃ OCO-(4-Br—C₆H₄) 3-pyridyl 25 OH OCOCH₃ OCOCH₃ OCO-(4-N₃—C₆H₄) 3-pyridyl 26 OH OCOCH₃ OCOCH₃ OCO-(4-OCF₃—C₆H₄) 3-pyridyl 27 OH OCOCH₃ OCOCH₃ OCO-(4-SO₂CF₃—C₆H₄) 3-pyridyl 28 OH OCOCH₃ OCOCH₃ OCO-(3-pyridyl) 3-pyridyl 29 OH OCOCH₃ OCOCH₃ OCO-(2-Cl-3-pyridyl) 3-pyridyl 30 OH OCOCH₃ OCOCH₃ OCO-(2-franyl) 3-pyridyl 31 OH OCOCH₃ OCOCH₃ OCO-(2-thiazolyl) 3-pyridyl 32 OH OCOCH₃ OCOCH₃ OCO-(2-Cl-5-thiazolyl) 3-pyridyl 33 OH OCOCH₃ OCOCH₃ OCO-(5-imidazolyl) 3-pyridyl 34 OH OCOCH₃ OCOCH₃ OCS-(1-imidazolyl) 3-pyridyl 35 OH OCOCH₃ OCOCH₃ OCOOCH₂C₆H₅ 3-pyridyl 36 OH OCOCH₃ OCOCH₃ OSO₂CH₃ 3-pyridyl 37 OH OCOCH₃ OCOCH₃ OSO₂C₆H₅ 3-pyridyl 38 OH OCOCH₃ OCOCH₃ OCONHCH₂CH₃ 3-pyridyl 39 OH OCOCH₃ OCOCH₃ OCONH(CH₂)CH₃ 3-pyridyl 40 OH OCOCH₃ OCOCH₃ OCONHCH₂C₆H₅ 3-pyridyl

TABLE 3 Compound No. R₁ R₂ R₃ R₄ Het₁ 41 OH OCOCH₃ OCOCH₃ OCH₂C₆H₅ 3-pyridyl 42 OH OCOCH₃ OCOCH₃ OCH₂SCH₃ 3-pyridyl 43 OH OCOCH₃ OCOCH₃ OCH₂OCH₃ 3-pyridyl 44 OH OCOCH₃ OCOCH₃ OCH₂OCH₂CH₂OCH₃ 3-pyridyl 45 OH OCOCH₃ OCOCH₃ O-(2-tetrahydropyranyl) 3-pyridyl 46 OH OCOCH₃ OCOCH₃ O-(tetra-O-benzyl-mannosyl) 3-pyridyl 47 OH OCOCH₃ OCOCH₃ H 3-pyridyl 48 OH OCOCH₃ OCOCH₃ OCO—c-C₃H₅ 3-pyridyl 49 OH OCOCH₃ OCOCH₃ OH 3-pyridyl 50 OH OCOCH₃ OCOCH₃ ═O 3-pyridyl 51 OH OCOCH₃ OCOCH2CH3 OCOCH₃ 3-pyridyl 52 OH OCOCH₃ OCOCH2CH3 OCOCH₂CH₃ 3-pyridyl 53 OH OCOCH₃ OCOCH₂CH₃ H 3-pyridyl 54 OH OCOCH₃ OCO(CH₂)₂CH₃ OCOCH₃ 3-pyridyl 55 OH OCOCH₃ OCO(CH₂)₂CH₃ OH 3-pyridyl 56 OH OCOCH₃ OCO(CH₂)₃CH₃ OCOCH₃ 3-pyridyl 57 OH OCOCH₃ OCOCH(CH)₃)₂ OCOCH₃ 3-pyridyl 58 OH OCOCH₃ OCOC₆H₅ OCOCH₃ 3-pyridyl 59 OH OCOCH₃ OCOC₆H₅ OH 3-pyridyl 60 OH OCOCH₃ OCS-(1-imidazolyl) OCOCH₃ 3-pyridyl

TABLE 4 Compound No. R₁ R₂ R₃ R₄ Het₁ 61 OH OCOCH₃ OSO₂CH₃ OCOCH₃ 3-pyridyl 62 OH OCOCH₃ OSO₂CH₃ OCO(CH₂)₃CH₃ 3-pyridyl 63 OH OCOCH₃ OSO₂C₆H₅ OCOCH₃ 3-pyridyl 64 OH OCOCH₃ OSO₂CH₂CH₃ OCOCH₃ 3-pyridyl 65 OH OCOCH₃ OSO₂CH₂CH₂CH₃ OCOCH₃ 3-pyridyl 66 OH OCOCH₃ OSO₂CH₂CH₃ OH 3-pyridyl 67 OH OCOCH₃ OSO₂CH₂CH₂CH₃ OH 3-pyridyl 68 OH OCOCH₃ OH OH 3-pyridyl 69 OH OCOCH₃ OH OCOCH₃ 3-pyridyl 70 OH OCOCH₃ H H 3-pyridyl 71 OH OCOCH₃ H OCOCH₂CH₃ 3-pyridyl 72 OH OCOCH₂CH₃ OCOCH₃ OCOCH₃ 3-pyridyl 73 OH OCOCH₂CH₃ OCOCH₂CH₃ OH 3-pyridyl 74 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₃ 3-pyridyl 75 OH OCOCH₂CH₃ OCOCH₃ OCOCH₂CH₃ 3-pyridyl 76 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂CH₃ 3-pyridyl 77 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOC₆H₅ 3-pyridyl 78 OH OCOCH₂CH₃ OCOCH₂CH₃ H 3-pyridyl 79 OH OCOCH₂CH₃ H H 3-pyridyl 80 OH OCO(CH₂)₂CH₃ OCOCH₃ OCOCH₃ 3-pyridyl

TABLE 5 Compound No. R₁ R₂ R₃ R₄ Het₁ 81 OH OCO(CH₂)₂CH₃ OCO(CH₂)₂CH₃ OH 3-pyridyl 82 OH OCO(CH₂)₂CH₃ OCO(CH₂)₂CH₃ OCO(CH₂)₂CH₃ 3-pyridyl 83 OH OCO(CH₂)₂CH₃ OCO(CH₂)₂CH₃ OCOCH₃ 3-pyridyl 84 OH OCO(CH₂)₃CH₃ OCOCH₃ OCOCH₃ 3-pyridyl 85 OH OCO(CH₂)₃CH₃ OCO(CH₂)₃CH₃ OCO(CH₂)₃CH₃ 3-pyridyl 86 OH OCO(CH₂)₃CH₃ OSO₂CH₃ OCO(CH₂)₃CH₃ 3-pyridyl 87 OH OCO(CH₂)₃CH₃ OSO₂CH₃ OH 3-pyridyl 88 OH OCO(CH₂)₁₆CH₃ OCO(CH₂)₁₆CH₃ OCO(CH₂)₁₆CH₃ 3-pyridyl 89 OH OCOCH(CH₃)₂ OCOCH₃ OCOCH₃ 3-pyridyl 90 OH OCOCH(CH₃)₂ OCOCH(CH₃)₂ OCOCH(CH₃)₂ 3-pyridyl 91 OH OCOC(CH₃)₃ OCOC(CH₃)₃ OCOC(CH₃)₃ 3-pyridyl 92 OH OCOC₆H₅ OCOCH₃ OCOCH₃ 3-pyridyl 93 OH OCOC₆H₅ OSO₂CH₃ OH 3-pyridyl 94 OH OCOC₆H₅ OSO₂CH₃ OCOCH₃ 3-pyridyl 95 OH OCOC₆H₅ OSO₂CH₃ OCO(CH₂)₃CH₃ 3-pyridyl 96 OH OCO-(4-Br—C₆H₄) OCO-(4-Br—C₆H₄) OCO-(4-Br—C₆H₄) 3-pyridyl 97 OH OCO-(4-N₃—C₆H₄) OSO₂CH₃ OCOCH₃ 3-pyridyl 98 OH OSO₂CH₃ OSO₂CH₃ OH 3-pyridyl 99 OH OSO₂CH₃ OSO₂CH₃ OSO₂CH₃ 3-pyridyl 100 OH OSO₂CH₃ OSO₂CH₃ OCOCH₃ 3-pyridyl

TABLE 6 Compound No. R₁ R₂ R₃ R₄ Het₁ 101 OH OSO₂CH₃ OH OH 3-pyridyl 102 OH OH OH OH 3-pyridyl 103 OH OH OH OCOCH₃ 3-pyridyl 104 OH OH OH OCO(CH₂)₃CH₃ 3-pyridyl 105 OH OH OH OCH₂OCH₂CH₂OCH₃ 3-pyridyl 106 OH OH OCOCH₃ OH 3-pyridyl 107 OH OH OCOCH₂CH₃ OH 3-pyridyl 108 OH OH OCO(CH₂)₂CH₃ OH 3-pyridyl 109 OH OH OCO(CH₂)₃CH₃ OH 3-pyridyl 110 OH OH OCOCH(CH₃)₂ OH 3-pyridyl 111 OH OH OSO₂CH₃ OH 3-pyridyl 112 OH OH OSO₂CH₂CH₃ OH 3-pyridyl 113 OH OH OSO₂CH₂CH₂CH₃ OH 3-pyridyl 114 OH OH OSO₂CH(CH₃)₂ OH 3-pyridyl 115 OH OH OSO₂C₆H₅ OH 3-pyridyl 116 OH OH OSO₂-(4-CH₃—C₆H₄) OH 3-pyridyl 117 OH OH OCO-(4-Br—C₆H₄) OH 3-pyridyl 118 OH OH OCO(CH₂)₃CH₃ OCO(CH₂)₃CH₃ 3-pyridyl 119 OH OH OSO₂CH₃ OSO₂CH₃ 3-pyridyl 120 OH OH OSO₂CH₃ OCOCH₃ 3-pyridyl

TABLE 7 Compound No. R₁ R₂ R₃ R₄ Het₁ 121 OH OH OSO₂CH₃ OCOCH₃ 3-pyridyl 122 OH OH OSO₂CH₃ OCO(CH₂)₃CH₃ 3-pyridyl 123 OH OH OSO₂C₆H₅ OCOCH₃ 3-pyridyl 124 OH OH OSO₂C₆H₅ OSO₂C₆H₅ 3-pyridyl 125 OH —O—CH(CH₃)—O— OCO(CH₂)₃CH₃ 3-pyridyl 126 OH —O—CH(C₂H₅)—O— OH 3-pyridyl 127 OH —O—CH(C₂H₅)—O— OCO(CH₂)₃CH₃ 3-pyridyl 128 OH —O—CH(CH═CH₂)—O— OH 3-pyridyl 129 OH —O—CH(CH═CH₂)—O— OCO(CH₂)₃CH₃ 3-pyridyl 130 OH —O—CH(CH(CH₃)₂)—O— OH 3-pyridyl 131 OH —O—CH(CH(CH₃)₂)—O— OCO(CH₂)₃CH₃ 3-pyridyl 132 OH —O—CH(OCH₃)—O— OH 3-pyridyl 133 OH —O—CH(C(CH₃)₃)—O— OCO(CH₂)₃CH₃ 3-pyridyl 134 OH —O—CH(CH₂C₆H₅)—O— OH 3-pyridyl 135 OH —O—C(CH₃)₂—O— OH 3-pyridyl 136 OH —O—C(CH₃)₂—O— OCOCH₃ 3-pyridyl 137 OH —O—C(CH₃)₂—O— OCO(CH₂)₃CH₃ 3-pyridyl 138 OH —O—C(CH₃C₆H₅)—O— OH 3-pyridyl 139 OH —O—C(CH₃)(C₆H₅)—O— OCO(CH₂)₃CH₃ 3-pyridyl 140 OH —O—CH(C₆H₅)—O— OH 3-pyridyl

TABLE 8 Compound No. R₁ R₂ R₃ R₄ Het₁ 141 OH —O—CH(C₆H₅)—O— OCOCH₃ 3-pyridyl 142 OH —O—CH(OCH₃)—O— OCO(CH₂)₃CH₃ 3-pyridyl 143 OH —O—CH(C₆H₅)—O— OCO(CH₂)₃CH₃ 3-pyridyl 144 OH —O—CH(3-CH₃—C₆H₄)—O— OH 3-pyridyl 145 OH —O—CH(3-CH₃—C₆H₄)—O— OCO(CH₂)₃CH₃ 3-pyridyl 146 OH —O—CH(2-CH₃—C₆H₄)—O— OH 3-pyridyl 147 OH —O—CH(4-CH₃—C₆H₄)—O— OCO(CH₂)₃CH₃ 3-pyridyl 148 OH —O—CH(3-F—C₆H₄)—O— OH 3-pyridyl 149 OH —O—CH(2-F—C₆H₄)—O— OCO(CH₂)₃CH₃ 3-pyridyl 150 OH —O—CH(4-F—C₆H₄)—O— OCO(CH₂)₃CH₃ 3-pyridyl 151 OH —O—CH(4-NO₂—C₆H₄)—O— OH 3-pyridyl 152 OH —O—CH(4-NO₂—C₆H₄)—O— OCO(CH₂)₃CH₃ 3-pyridyl 153 OH —O—CH(4-OCH₃—C₆H₄)—O— OH 3-pyridyl 154 OH —O—CH(4-OCH₃—C₆H₄)—O— OCO(CH₂)₃CH₃ 3-pyridyl 155 OH —O—C(spiro-c-C₅H₈)—O— OH 3-pyridyl 156 OH —O—C(spiro-c-C₅H₈)—O— OCO(CH₂)₃CH₃ 3-pyridyl 157 OH —O—C(spiro-c-C₆H₁₀)—O— OH 3-pyridyl 158 OH —O—C(spiro-c-C₆H₁₀)—O— OCO(CH₂)₃CH₃ 3-pyridyl 159 OH —O—CO—O— OH 3-pyridyl 160 OH —O—CO—O— OCO-1-imidazolyl 3-pyridyl

TABLE 9 Compound No. R₁ R₂ R₃ R₄ Het₁ 161 OH —O—CO—O— OCO(CH₂)₃CH₃ 3-pyridyl 162 OCOCH₃ OCOCH₃ OCOCH₃ OCOCH₃ 3-pyridyl 163 OCOCH₃ OCOCH₃ OCOCH₃ OH 3-pyridyl 164 OCOCH₃ OCOCH₃ OCO(CH₂)₂CH₃ OCOCH₃ 3-pyridyl 165 OCOCH₃ OH OH OCOCH₃ 3-pyridyl 166 OCOCH₃ OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂CH₃ 3-pyridyl 167 OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂CH₃ 3-pyridyl 168 OCOCH₂CH₃ OCOCH₃ OCOCH₃ OCOCH₃ 3-pyridyl 169 OCO(CH₂)₃CH₃ OCOCH₃ OCOCH₃ OCOCH₃ 3-pyridyl 170 OCO(CH₂)₃CH₃ OCOCH₃ OCOCH₃ OCO(CH₂)₃CH₃ 3-pyridyl 171 OCO(CH₂)₂CH₃ OCOCH₃ OCOCH₃ OCOCH₃ 3-pyridyl 172 OCH₃ OCOCH₃ OCOCH₃ OCOCH₃ 3-pyridyl 173 H(═) OSO₂CH₃ OSO₂CH₃ OH 3-pyridyl 174 H(═) OCOC₆H₅ OSO₂CH₃ OCOCH₃ 3-pyridyl 175 H(═) OH OH OCOCH₃ 3-pyridyl 176 H(═) OCOCH₃ OCOCH₃ ═O 3-pyridyl 177 H(═) —O—CH(C₆H₅)—O— OCOCH₃ 3-pyridyl 178 H(═) —O—CH(CH(CH₃)₂)—O— OH 3-pyridyl 179 H(═) —O—CH(4-NO₂—C₆H₄)—O— OH 3-pyridyl 180 H(═) OCOCH₃ OCOCH₃ OCOCH₃ 3-pyridyl

TABLE 10 Compound No. R₁ R₂ R₃ R₄ Het₁ 181 H(═) OH OH OH 3-pyridyl 182 H(═) OCOCH₃ OCOCH₃ OH 3-pyridyl 183 H(═) OCOCH₃ OCOCH₃ OCH₂SCH₃ 3-pyridyl 184 H(═) OCOCH₃ OCOCH₃ OCH₂OCH₃ 3-pyridyl 185 H(═) OCOCH₃ OCOCH₃ OCO(CH₂)₃CH₃ 3-pyridyl 186 H(═) OCOCH₃ OCOCH₃ OCO(CH₂)₂Ph 3-pyridyl 187 H(═) OCOCH₃ OSO₂CH₃ OCOCH₃ 3-pyridyl 188 H(═) OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂CH₃ 3-pyridyl 189 H(═) OCOCH₂CH₃ OCOCH₂CH₃ OH 3-pyridyl 190 H(═) OH OSO₂CH₃ OH 3-pyridyl 191 H(═) OH OH OCO(CH₂)₃CH₃ 3-pyridyl 192 H(═) —O—C(CH₃)₂—O— OH 3-pyridyl 193 H(═) —O—C(CH₃)₂—O— OCO(CH₂)₃CH₃ 3-pyridyl 194 H(═) —O—CH(C₆H₅)—O— OH 3-pyridyl 195 H(═) —O—CH(C₆H₅)—O— OCO(CH₂)₃CH₃ 3-pyridyl 196 H(═) —O—CH(4-OCH₃—C₆H₄)—O— OH 3-pyridyl 197 H(═) —O—CH(C₂H₅)—O— OH 3-pyridyl 198 H(═) —O—CH(C(CH₃)₂)—O— OH 3-pyridyl 199 H(═) —O—CH(CH₂C₆H₅)—O— OH 3-pyridyl 200 ═O OH OH OH 3-pyridyl

TABLE 11 Compound No. R₁ R₂ R₃ R₄ Het₁ 201 ═O OCOCH₃ OCOCH₃ ═O 3-pyridyl 202 ═O OCOCH₃ OCOCH₃ OH 3-pyridyl 203 ═O OCOCH₃ OCOCH₃ OCOCH₃ 3-pyridyl 204 ═O OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂CH₃ 3-pyridyl 205 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3-Pyridyl) 3-pyridyl 206 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOCH(CH₃)₂ 3-pyridyl 207 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOC(CH₃)₃ 3-pyridyl 208 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(4-CF₃—C₆H₄) 3-pyridyl 209 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(1-imidazolyl) 3-pyridyl 210 OH OCOCH₂CH₃ OCOCH₂CH₃ OCONH(CH₂)₂CH₃ 3-pyridyl 211 OH OCOCH₂CH₃ OCOCH₂CH₃ O-(2-tetrahydropyranyl) 3-pyridyl 212 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(6-Cl-3-pyridyl) 3-pyridyl 213 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO—c-C₃H₅ 3-pyridyl 214 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO—c-C₄H₇ 3-pyridyl 215 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOCH═CH 3-pyridyl 216 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(4-pyridyl) 3-pyridyl 217 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(2-pyridyl) 3-pyridyl 218 OH OCO—c-C₃H₅ OCO—c-C₃H₅ OCO—c-C₃H₅ 3-pyridyl 219 OH OCO—c-C₄H₇ OCO—c-C₄H₇ OCO—c-C₄H₇ 3-pyridyl 220 OH OCOC₆H₅ OCOC₆H₅ OCOC₆H₅ 3-pyridyl

TABLE 12 Compound No. R₁ R₂ R₃ R₄ Het₁ 221 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(6-CF₃-3-pyridyl) 3-pyridyl 222 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(4-CF₃-3-pyridyl) 3-pyridyl 223 OH OCOCH₂CH₃ OCOCH₂CF₃ OCOCH₂CF₃ 3-pyridyl 224 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂CF₃ 3-pyridyl 225 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂CH₃ 3-pyridyl 226 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂CH₃ 3-pyridyl 227 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3-F-4-pyridyl) 3-pyridyl 228 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3-Cl-4-pyridyl) 3-pyridyl 229 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3-CH₃-2-pyridyl) 3-pyridyl 230 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3-COC₆H₅-2-pyridyl) 3-pyridyl 231 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3-OCH₂CH₂CH₃-2-pyridyl) 3-pyridyl 232 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(6-F-3-pyridyl) 3-pyridyl 233 OH OCO—c-C₅H₉ OCO—c-C₅H₉ OCO—c-C₅H₉ 3-pyridyl 234 OH OCO—c-C₆H₁₁ OCO—c-C₆H₁₁ OCO—c-C₆H₁₁ 3-pyridyl 235 OH OCOCH₂CN OCOCH₂CN OCOCH₂CN 3-pyridyl 236 OCOCH₂—c-C₃H₅ OCOCH₂—c-C₃H₅ OCOCH₂—c-C₃H₅ OCOCH₂—c-C₃H₅ 3-pyridyl 237 OH OCOCH₂—c-C₃H₅ OCOCH₂—c-C₃H₅ OCOCH₂—c-C₃H₅ 3-pyridyl 238 OH OCO-(1-CH₃-2,2-diF—c-C₃H₂) OCO-(1-CH₃-2,2-diF—c-C₃H₂) OCO-(1-CH₃-2,2-diF—c-C₃H₂) 3-pyridyl 239 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(4-CH₃-3-pyridyl) 3-pyridyl 240 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(4-Cl-3-pyridyl) 3-pyridyl

TABLE 13 Compound No. R₁ R₂ R₃ R₄ Het₁ 241 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(4-COOCH₃-3-pyridyl) 3-pyridyl 242 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-[5-(CF₃)-thieno[3,2-b]pyridin-6-yl] 3-pyridyl 243 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(2-CN—C₆H₄) 3-pyridyl 244 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(2-CF₃—C₆H₄) 3-pyridyl 245 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(2-F—C₆H₄) 3-pyridyl 246 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(2-NO₂—C₆H₄) 3-pyridyl 247 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(2-Cl-3-pyridyl) 3-pyridyl 248 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(2-Cl-6-CH₃-3-pyridyl) 3-pyridyl 249 OH OCOCH₂CH₃ OCOCH₂CH₃ OCH₂OCH₃ 3-pyridyl 250 OH OCO-(2,2-diF—c-C₃H₃) OCO-(2,2-diF—c-C₃H₃) OCO-(2,2-diF—c-C₃H₃) 3-pyridyl 251 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3-SC(CH₃)₃-2-pyridyl) 3-pyridyl 252 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3,5-diF-2-pyridyl) 3-pyridyl 253 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-2-pyrazinyl 3-pyridyl 254 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-4-thiazolyl 3-pyridyl 255 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3-Cl-2-thienyl) 3-pyridyl 256 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(6-CH₃-3-pyridyl) 3-pyridyl 257 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(6-Cl-2-pyridyl) 3-pyridyl 258 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(6-F-2-pyridyl) 3-pyridyl 259 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(1-CH₃—1H-indolyl) 3-pyridyl 260 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3-Cl-2-pyridyl) 3-pyridyl

TABLE 14 Compound No. R₁ R₂ R₃ R₄ Het₁ 261 OH OCO-c-C₃H₅ OCO-c-C₃H₅ OH 3-pyridyl 262 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(2-F-3-pyridyl) 3-pyridyl 263 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(4-CN—C₆H₄) 3-pyridyl 264 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3-CN—C₆H₄) 3-pyridyl 265 OH OCOCH₂CH₃ OCOCH₂CH₃ OCO-(3-CF₃—C₆H₄) 3-pyridyl 266 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂(2-pyridyl) 3-pyridyl 267 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂(3-pyridyl) 3-pyridyl 268 OH OCOCH₂CH₃ OCOCH₂CH₃ OCOCH₂S(4-pyridyl) 3-pyridyl 269 OH OCO-c-C₃H₅ OCO-c-C₃H₅ OCO-(2-CN—C₆H₄) 3-pyridyl 270 OH OCO-c-C₃H₅ OCO-c-C₃H₅ OCO-(4-CF₃-3-pyridyl) 3-pyridyl 271 OH OCO-c-C₃H₅ OCO-c-C₃H₅ OCO-(3-Cl-2-pyridyl) 3-pyridyl 272 OH —O—CH(C₆H₅)—O— ═O 3-pyridyl 273 OH —O—CH(4-OCH₃—C₆H₄)—O— ═O 3-pyridyl 274 OCO(CH₂)₃CH₃ —O—CO—O— OCO(CH₂)₃CH3 3-pyridyl 275 OCOCH₃ —O—CH(C₆H₅)—O— OCOCH₃ 3-pyridyl 276 ═O —O—CH(4-OCH₃—C₆H₄)—O— OH 3-pyridyl

Production Process

The composition according to the present invention can be prepared by mixing the compound represented by formula (I), (Ia), or (Ib) as active ingredient with an agriculturally and horticulturally acceptable carrier. The compound represented by formula (I), (Ia), or (Ib) according to the present invention can be produced according to the following procedure.

Among the compounds according to the present invention, the compounds represented by formula (II) can be synthesized by the method described in Japanese Patent Laid-Open Publication No. 259569/1996, Japanese Patent Laid-Open Publication No. 269062/1996, Japanese Patent Laid-Open Publication No. 269065/1996, or Journal of Antibiotics (1997), 50(3), pp. 229-36. When pyripyropene A is used as a starting material, pyripyropene A, produced by the method described in Journal of Society of Synthetic Organic Chemistry, Japan (1998), Vol. 56, No. 6, pp. 478-488 or WO 94/09417, may be used as the starting material.

wherein

-   -   R₁ represents hydroxyl, optionally substituted C₁₋₆         alkylcarbonyloxy, optionally substituted C₂₋₆         alkenylcarbonyloxy, optionally substituted C₂₋₆ alkynyl         carbonyloxy, optionally substituted C₁₋₆ alkyloxy, optionally         substituted C₂₋₆ alkenyloxy, optionally substituted C₂₋₆         alkynyloxy, optionally substituted benzyloxy, or oxo in the         absence of a hydrogen atom at the 13-position, and     -   R₂, R₃ and R₄ are as defined in formula (I).

Further, among the compounds according to the present invention, the compounds represented by formula (III) can be synthesized by the method described in Japanese Patent Laid-Open Publication No. 269063/1996, Japanese Patent Laid-Open Publication No. 269066/1996.

-   -   wherein R₂, R₃ and R₄ are as defined in formula (I).

Use

Insect species against which pyripyropene derivatives of formula (I) or (Ib) according to the present invention have control effect include: Iepidopteran pests, for example, Spodoptera litura, Mamestra brassicae, Pseudaletia separata, green caterpillar, Plutella xylostella, Spodoptera exigua, Chilo suppressalis, Cnaphalocrocis medinalis, Tortricidae, Carposinidae, Lyonetildae, Lymantriidae, pests belonging to the genus Agrotis spp., pests belonging to the genus Helicoverpa spp., and pests belonging to the genus Heliothis spp.; hemipteran pests, for example, Aphidoidea including Aphididae, Adelgidae and Phylloxeridae such as Myzus persicae, Aphis gossypii, Aphis fabae, Aphis maidis (corn-leaf aphid), Acyrthosiphon pisum, Aulacorthum solani, Aphis craccivora, Macrosiphum euphorbiae, Macrosiphum avenae, Metopolophium dirhodum, Rhopalosiphum padi, Schizaphis graminum, Brevicoryne brassicae, Lipaphis erysimi, Aphis citricola, Rosy apple aphid, Eriosorna lanigerum, Toxoptera aurantii, and Toxoptera citricidus; Deitocephalidae such as Nephotettix cincticeps, Delphacidae such as Laodelphax striatellus, Nilaparvata lugens, and Sogatella furcifera; Pentatomidae such as Eysarcoris ventralis, Nezara viridula, and Trigonotylus coelestiafium; Aleyrodidae such as Bemisia argentifolii, Bemisia tabaci, and Trialieurodes vaporariorum; Diaspididae, Margarodidae, Ortheziidae, Aclerdiae, Dactylopiidae, Kerridae, Pseudococcidae, Coccidae, Eriococcidae, Asterolecaniidae, Beesonidae, Lecanodiaspididae, or Cerococcidae, such as Pseudococcus comstocki and Planococcus citri Risso; Coleoptera pests, for example, Lissorhoptrus oryzophilus, Caflosobruchuys chienensis, Tenebrio molitor, Diabrotica virgifera virgifera, Diabrotica undecimpunctata howardi, Anomala cuprea, Anomala rufocuprea, Phyllotreta striolata, Aulacophora femoralis, Leptinotarsa decemlineata, Oulema oryzae, Carposinidae, and Cerambycidae; Acari, for example, Tetranychus urticae, Tetranychus kanzawai, and Panonychus citri; Hymenopteran pests, for example, Tenthredinidae; Orthopteran pests, for example, Acrididae; Dipteran pests, for example, Museidae and Agromyzidae; Thysanopteran pests, for example, Thrips palmi and Frankliniella occidentalis; Plant Parasitic Nematodes, for example, Meloidogyne hapla, Pratylenchus spp., Aphelenchoides besseyi and Bursaphelenchus xylophilus; and parasites of animals, for example, Siphonaptera, Anoplura, mites such as Boophilus microplus, Haemaphysalis longicornis, Rhipicephalus sanguineus, and Scarcoptes scabiei. Preferred are hemipteran pests.

The compound represented by formula (Ia) accordingly to the present invention has significant control effect against hemipteran pests. Preferred hemipteran pests are selected from Aphidoidea such as Aphididae, Adelgidae, and Phylloxeridae, particularly preferably Aphididae; Coccoidea such as Diaspididae, Margarodidae, Ortheziidae, Aclerdiae, Dactylopiidae, Kerridae, Pseudococcidae, Coccidae, Eriococcidae, Asterolecaniidae. Beesonidae, Lecanodiaspididae, and Cerococcidae; and Aleyrodidae. More preferred are Myzus persicae, Aphis gossypii, Aphis fabae, Aphis maidis (corn-leaf aphid), Acyrthosiphon pisum, Aulacorthum solani, Aphis craccivora, Macrosiphum euphorbiae, Macrosiphum avenae, Metopolophium dirhodum, Rhopafosiphum padi, Schizaphis graminum, Brevicoryne brassicae, Lipaphis erysimi, Aphis citricoia, Rosy apple aphid, Eriosoma lanigerum, Toxoptera aurantii, Toxoptera citricidus, and Pseudoeoccus comstocki.

The composition according to the present invention can be prescribed in any suitable formulation, such as emulsifiable concentrates, liquid formulations, suspension, wettable powder, flowables, dust, granules, tablets, oil solutions, aerosols, or smoking agents by using suitable agriculturally and horticulturally acceptable carriers. Accordingly, the carrier include solid carriers, liquid carriers, gaseous carriers, surfactants, dispersants and/or other adjuvants for formulations, and the like.

Solid carriers usable herein include, for example, talc, bentonite, clay, kaolin, diatomaceous earth, vermiculite, white carbon, and calcium carbonate.

Examples of liquid carriers include: alcohols, such as methanol, n-hexanol, and ethylene glycol; ketones, such as acetone, methyl ethyl ketone, and cyclohexanone; aliphatic hydrocarbons, such as n-hexane, kerosine, and kerosene; aromatic hydrocarbons, such as toluene, xylene, and methylnaphthalene; ethers, such as diethyl ether, dioxane, and tetrahydrofuran; esters, such as ethyl acetate; nitriles, such as acetonitrile and isobutyronitrile; acid amides, such as dimethylformamide and dimethylacetamide; vegetable oils, such as soy bean oil and cotton seed oil; dimethylsulfoxide; and water.

Gaseous carriers include, for example, LPG, air, nitrogen, carbon dioxide, and dimethyl ether.

Surfactants or dispersants usable, for example, for emulsifying, dispersing, or spreading include, for example, alkylsulfonic esters, alkyl(aryl)sulfonic acid salts, polyoxyalkylene alkyl(aryl) ethers, polyhydric alcohol esters, and lignin sulfonic acid salts.

Adjuvants usable for improving the properties of formulations include, for example, carboxymethylcellulose, gum arabic, polyethylene glycol, and calcium stearate.

The above carriers, surfactants, dispersants, and adjuvant may be used either solely or in combination according to need.

The content of the active ingredient in the formulation is not particularly limited. In general, however, the content of the active ingredient is 1 to 75% by weight for emulsifiable concentrates, 0.3 to 25% by weight for dust, 1 to 90% by weight for wettable powder, and 0.5 to 10% by weight for granules.

The compound represented by formula (I), (Ia), (Ib), or an agriculturally and horticulturally acceptable salt thereof and the above formulations comprising the same may be applied as such or after dilution to plants or soil. Therefore, according to another aspect of the present invention, there is provided a method for controlling a pest, comprising applying an effective amount of a compound represented by formula (I) or an agriculturally and horticulturally acceptable salt thereof to a plant or soil. According to still another aspect of the present invention, there is provided a method for controlling a hemipteran pest, comprising applying an effective amount of a compound represented by formula (Ia) or an agriculturally and horticulturally acceptable salt thereof to a plant or soil. According to a further aspect of the present invention, there is provided a method for controlling a pest, comprising applying an effective amount of a compound represented by formula (Ib) or an agriculturally and horticulturally acceptable salt thereof to a plant or soil. Preferred methods usable for applying the compound or formulation to plants or soil include spreading treatment, soil treatment, surface treatment, and fumigation treatment.

Spreading treatments include, for example, spreading, spraying, misting, atomizing, granule application, and submerged application. Soil treatments include, for example, soil affusion and soil mixing. Examples of surface treatments include, for example, coating, dust coating, and covering. Fumigation treatments include, for example, covering of soil with a polyethylene film after soil injection. Accordingly, the control method according to the present invention comprises a method in which the compound represented by formula (I), (Ia), or (Ib) or a formulation comprising the same is applied by fumigation in a sealed space.

The composition according to the present invention may be used as a mixture or in a combination with, for example, other insecticides, fungicides, miticides, herbicides, plant growth-regulating agents, or fertilizers. Agents which may be mixed or used in combination include those described, for example, in The Pesticide Manual, 13th edition, published by The British Crop Protection Council; and SHIBUYA INDEX, the 10th edition, 2005, published by SHIBUYA INDEX RESEARCH GROUP. More specifically, insecticides usable herein include, for example, organophosphate ester compounds such as acephate, dichlorvos, EPN, fenitrothion, fenamifos, prothiofos, profenofos, pyraclofos, chlorpyrifos-methyl, and diazinon; carbamate compounds such as methomyl, thiodicarb, aidicarb, oxamyl, propoxur, carbaryl, fenobucarb, ethiofencarb, fenothiocarb, pirmicarb, carbofuran, and benfuracarb; nereistoxin derivatives such as cartap and thiocyclam; organochlorine compounds such as dicofol and tetradifon; pyrethroid compounds such as permethrin, tefluthrin, cypermethrin, deltamethrin, cyhalothrin, fenvalerate, fluvalinate, ethofenprox, and silafluofen; benzoyl urea compounds such as diflubenzuron, teflubenzuron, flufenoxuron, and chlorfluazuron; juvenile hormone-like compounds such as methoprene; and molting hormone-like compounds such as chromafenozide. Other compounds usable herein include buprofezin, hexythiazox, amitraz, chlordimeform, pyridaben, fenpyroxymate, pyrimidifen, tebufenpyrad, fluacrypyrim, acequinocyl, cyflumetofen, flubendiamide, ethiprole, fipronil, ethoxazole, imidacloprid, chlothianrdin, pymetrozine, bifenazate, spirodiclofen, spiromesifen, flonicamid, chlorfenapyr, pyriproxyfene, indoxacarb, pyridalyl, or spinosad, avermectin, milbemycin, organometallic compounds, dinitro compounds, organosulfur compounds, urea compounds, triazine compounds, hydrazine compounds.

The composition according to the present invention may also be used as a mixture or in a combination with microbial pesticides such as BT formulations and entomopathogenic viral agents.

Fungicides usable herein include, for example, strobilurin compounds such as azoxystrobin, kresoxym-methyl, and trifloxystrobin; anilinopyrimidine compounds such as mepanipyrim, pyrimethanil, and cyprodinil; azole compounds such as triadimefon, bitertanol, triflumizole, etaconazole, propiconazole, penconazole, flusilazole, myclobutanil, cyproconazole, tebuconazole, hexaconazole, prochloraz, and simeconazole; quinoxaline compounds such as quinomethionate; dithiocarbamate compounds such as maneb, zineb, mancozeb, polycarbamate, and propineb; phenylcarbamate compounds such as diethofencarb; organochlorine compounds such as chlorothalonil and quintozene; benzimidazole compounds such as benomyl, thiophanate-methyl, and carbendazole; phenylamide compounds such as metalaxyl, oxadixyl, ofurace, benalaxyl, furalaxyl, and cyprofuram; sulfenic acid compounds such as dichlofluanid; copper compounds such as copper hydroxide and oxine-copper; isoxazole compounds such as hydroxyisoxazole; organophosphorus compounds such as fosetyl-aluminium and tolclofos-methyl; N-halogenothioalkyl compounds such as captan, captafol, and folpet; dicarboxyimide compounds such as procymidone, iprodione, and vinchiozolin; benzanilide compounds such as flutolanil and mepronil; morpholine compounds such as fenproplmorph and dimethomorph; organotin compounds such as fenthin hydroxide, and fenthin acetate; and cyanopyrrole compounds such as fludioxonil and fenpiclonil. Other compounds usable herein include fthalide, fluazinam, cymoxanil, triforine, pyrifenox, fenarimol, fenpropidin, pencycuron, cyazofamid, iprovalicarb, and benthiavalicarb-isopropyl and the like.

According to another aspect of the present invention, there is provided use of a compound represented by formula (I) or an agriculturally and horticulturally acceptable salt thereof as a pest control agent. According to still another aspect of the present invention, there is provided use of a compound represented by formula (Ia) or an agriculturally and horticulturally acceptable salt thereof as a hemipteran pest control agent. According to still another aspect of the present invention, there is provided use of a compound represented by formula (Ib) or an agriculturally and horticulturally acceptable salt thereof as a pest control agent.

EXAMPLES

The present invention is further illustrated by the following Examples that are not intended as a limitation of the invention. The compound Nos. correspond to the compound Nos. in Tables 1 to 14.

Example 1 Synthesis of Compound 73

Compound 76 (890 mg) synthesized by the method described in Japanese Patent Laid-Open Publication No. 259569/1996 was dissolved in an 80% aqueous methanol solution. Next, 1,8-diazabicyclo[5.4.0]-undeca-7-ene (216 mg) was added to the solution, and the mixture was stirred at room temperature for 1.5 hr. The reaction mixture was added with acetic acid to quench the reaction, and the solvent was removed by evaporation under the reduced pressure. Water was added to the precipitated crystal, followed by extraction with chloroform. The chloroform layer was washed with saturated brine, was dried over anhydrous magnesium sulfate, and the solvent was removed by evaporation under the reduced pressure to give a crude product of compound 73. The crude product was purified by chromatography on silica gel (Mega Bond Elut (Varian), acetone:hexane=1:1) to give compound 73 (451 mg).

Mass spectrometric data (FAB⁺): 570(M+H)⁺

Example 2 Synthesis of Compound 218

Compound 102 (30 mg) synthesized by the method described in Japanese Patent Laid-Open Publication No. 259569/1996 and cyclopropanecarboxylic acid (112 mg) were dissolved in anhydrous N,N-dimethylformamide (2 ml), and 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (76 mg) and 4-(dimethylamino)pyridine (32 mg) were added to the solution. The reaction solution was stirred at room temperature for 68 hr and was then poured into water followed by extraction with ethyl acetate. The ethyl acetate layer was washed with saturated brine and was dried over anhydrous magnesium sulfate, and the solvent was removed by evaporation under the reduced pressure to give a crude product of compound 218. The crude product was purified by preparative thin-layer chromatography (Merck Silica Gel 60 F₂₅₄ 0.5 mm, acetone:hexane=1:1) to give compound 218 (33 mg).

Mass spectrometric data (FAB⁺): 662(M+H)⁺

Example 3 Synthesis of Compound 261

Compound 218 (1.07 g), prepared in Example 2 was dissolved in an 80% aqueous methanol solution. 1,8-Diazabicyclo[5.4.0]-undeca-7-ene (271 mg) was added to the solution, and the mixture was stirred at room temperature for 24.5 hr. The reaction mixture was added with acetic acid to quench the reaction, and the solvent was removed by evaporation under the reduced pressure. Water was added to the precipitated crystal, followed by extraction with chloroform. The chloroform layer was washed with saturated brine and was dried over anhydrous magnesium sulfate, and the solvent was removed by evaporation under the reduced pressure to give a crude product of compound 261. The crude product was purified by chromatography on silica gel (Mega Bond Elut (Varian), acetone:hexane=1:1) to give compound 261 (233 mg).

Mass spectrometric data (ESI⁺): 594(M+H)⁺

Example 4 Synthesis of Compound 222

Compound 73 (30 mg) prepared in Example 1 and 4-(trifluoromethyl)nicotinic acid (30 mg) was dissolved in anhydrous N,N-dimethylformamide (3 ml). Next, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (15 mg) and 4-(dimethylamino)pyridine (4 mg) were added to the solution, and the reaction solution was stirred at room temperature for 15 hr and was then poured into water, followed by extraction with ethyl acetate. The ethyl acetate layer was washed with saturated brine and was dried over anhydrous magnesium sulfate, and the solvent was removed by evaporation under the reduced pressure to give a crude produce of compound 222. The crude product was purified by preparative thin-layer chromatography (Merck Silica Gel 60 F₂₅₄ 0.5 mm, acetone:hexane=1:1) to give compound 222 (19 mg).

Mass spectrometric data (FAB⁺): 743(M+H)⁺

Example 5 Synthesis of Compound 269

Compound 261 (20 mg) prepared in Example 3 and 2-cyanobenzoic acid (30 mg) were dissolved in anhydrous N,N-dimethylformamide (1 ml), and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (26 mg) and 4-(dimethylamino)pyridine (4 mg) were added to the solution. The reaction solution was stirred at room temperature for 12 hr, and the reaction solution was added to water, followed by extraction with ethyl acetate. The ethyl acetate layer was washed with saturated brine and was dried over anhydrous magnesium sulfate. The solvent was removed by evaporation under the reduced pressure to give a crude product of compound 269. The crude product was purified by preparative thin-layer chromatography (Merck Silica Gel 80 F₂₅₄ 0.5 mm, acetone:hexane=1:1) to give compound 269 (18 mg).

Mass spectrometric data (ESI⁺): 723 (M+H)⁺

Example 6 Synthesis of Compound 225

1,7,11-Trideacetyl-13-Oxo-6″-chloropyripyropene A (10 mg) described in Journal of Antibiotics (1997), 50 (3), 229-38 was dissolved in anhydrous N,N-dimethylformamide (1 ml). Triethylamine (24 mg) and 4-(dimethylamino)pyridine (0.5 mg) were added to the solution, and the mixture was stirred at room temperature for 30 min. Thereafter, propionic acid anhydride (8 mg) was added. The reaction solution was stirred at the same temperature for 4 hr. The reaction solution was added to water, and the mixture was extracted with ethyl acetate. The ethyl acetate layer was washed with saturated brine and was dried over anhydrous magnesium sulfate, and the solvent was then removed by evaporation under the reduced pressure to give a crude product of compound 225. The crude product was purified by preparative thin-layer chromatography (Merck Silica Gel 60 F₂₅₄ 0.5 mm, acetone:hexane=1:1) to give compound 225 (5.6 mg).

Mass spectrometry data (ESI⁺): 658 (M+H)⁺

Example 7 Synthesis of Compound 226

Compound 225 (10 mg) prepared in Example 8 was dissolved in methanol (1 ml), Cerium(III) chloride heptahydrate (57 mg) and sodium borohydride (6 mg) were added to the solution. The mixture was stirred at 0° C. for 7 hr, and water was added to the reaction solution, followed by extraction with ethyl acetate. The ethyl acetate layer was washed with saturated brine and was dried over anhydrous magnesium sulfate, and the solvent was removed by evaporation under the reduced pressure to give a crude product of compound 226. The crude product was purified by preparative thin-layer chromatography (Merck Silica Gel 60 F₂₅₄ 0.5 mm, acetone:hexane=1:1) to give compound 226 (8.5 mg).

Mass spectrometry data (ESI⁺): 660 (M+H)⁺

Example 8 Synthesis of Compound 273

1,7,11-Trideacetyl-1,11-o-p-methoxybenzylidene pyripyropene A (10 mg) described in Japanese Patent Laid-Open Publication No. 269065/1996 was dissolved in anhydrous dichloromethane (0.5 ml), and pyridinium dichromate (PDC) (39 mg) was added to the solution. The reaction solution was stirred at room temperature for 4 hr. and the reaction solution was added to water. The dichloromethane layer was washed with saturated brome, and was dried over anhydrous sodium sulfate, and the solvent was then removed by evaporation under the reduced pressure to give a crude product of compound 273. The crude product was purified by preparative thin-layer chromatography (Merck Silica Gel 60 F₂₅₄ 0.5 mm, chloroform:methanol=12.5:1) to give compound 273 (4.4 mg).

Mass spectrometric data (ESI⁺): 574 (M+H)⁺

Example 9 Synthesis of Compound 274

1,11-o-Cyclic carbonate 1,7,11-trideacetyl-pyripyropene A (4 mg) described in Japanese Patent Laid-Open Publication No. 269085/1996 was dissolved in anhydrous dichloromethane (1 ml). Triethylamine (5 μl) and 4-(dimethylamino)pyridine (1 mg) were added to the solution. The reaction solution was stirred at room temperature for 30 min, and valeric acid anhydride (5 μl) was added thereto. Next, the reaction solution was stirred at room temperature for 3 hr. The reaction solution was added to water, and the dichloromethane layer was washed with saturated brine and was dried over anhydrous sodium sulfate. The solvent was then removed by evaporation under the reduced pressure to give a crude product of compound 274. The crude product was purified by preparative thin-layer chromatography (Merck Silica Gel 60 F₂₅₄ 0.5 mm, chloroform:methanol=25:1) to give compound 274 (0.1 mg).

Mass spectrometric data (ESI⁺): 652 (M+H)⁺

Example 10

Compounds shown in Tables 15 to 17 were synthesized using starting materials, reaction reagents 1 and 2 and solvents described in these tables. Further, the ¹H-NMR data about some of the compounds in Tables 15 to 17 was described in Tables 18 to 29. In addition, CDCl₃ was used as the solvent for the ¹H-NMR measurement. Tetramethylsilane was used as a standard substance for the ¹H-NMR measurement.

TABLE 15 Compound Starting material No. (Compound No.) Amount Reaction reagent 1 Amount Reaction reagent 2 74 73 30 mg acetic anhydride 32.7 mg Et₃N 64.0 mg, DMAP 12.8 mg 77 73 30 mg benzoic acid 84.8 mg EDCI 49.2 mg, DMAP 46.4 mg 91 102 30 mg pivalic anhydride 220 mg Et₃N 60.0 mg, DMAP 8.0 mg 205 73 30 mg nicotinic acid 12.9 mg EDCI 15.1 mg, DMAP 6.4 mg 206 73 30 mg isobutyric anhydride 50.0 mg Et₃N 64.0 mg, DMAP 12.8 mg 207 73 30 mg pivalic anhydride 58.9 mg Et₃N 64.0 mg, DMAP 12.8 mg 208 73 30 mg 4-(trifluoromethyl)benzoic anhydride 114 mg Et₃N 64.0 mg, DMAP 12.8 mg 209 73 40 mg 1,1-carbonyl diimidazole 34.0 mg — 210 73 30 mg propyl isocyanate 26.9 mg Et₃N 64.0 mg, DMAP 12.8 mg 211 73 30 mg 3,4-dihydro-2H-pyran 155 mg pyridine hydrochloride 212 73 30 mg 6-chloro nicotinic acid 16.5 mg EDCI 15.2 mg, DMAP 6.4 mg 213 73 30 mg cyclopropane carboxylic acid 27 mg EDCI 15.2 mg, DMAP 6.4 mg 214 73 30 mg cyclobutane carboxylic acid 31 mg EDCI 15.2 mg, DMAP 6.4 mg 215 73 30 mg acrylic acid 22.5 mg EDCI 15.2 mg, MAP 6.4 mg 216 73 30 mg isonicotinic acid 12.9 mg EDCI 15.2 mg, DMAP 6.4 mg 217 73 30 mg picolinic acid 12.9 mg EDCI 15.2 mg, DMAP 6.4 mg 219 102 30 mg cyclobutane carboxylic acid 131 mg EDCI 76 mg, DMAP 32 mg 220 102 30 mg benzoic acid 160 mg EDCI 126 mg, DMAP 80 mg 221 73 30 mg 6-(trifluoromethyl)nicotinic acid 30 mg EDCI 15.2 mg, DMAP 6.4 mg 223 102 30 mg 3,3,3-trifluoropropionic acid 168 mg EDCI 126 mg, DMAP 80 mg 224 73 30 mg 3,3,3-trifluoropropionic acid 20 mg EDCI 15.2 mg, DMAP 6.4 mg Compound Mass spectrometric data No. Solvent Yield Measuring Method Data 74 DMF 13.6 mg FAB 612 (M + H)⁺ 77 DMF 36.4 mg FAB 674 (M + H)⁺ 91 DMF 27.7 mg FAB 710 (M + H)⁺ 205 DMF 27.1 mg FAB 675 (M + H)⁺ 206 DMF 11.4 mg FAB 640 (M + H)⁺ 207 DMF 23.4 mg FAB 654 (M + H)⁺ 208 DMF 32.2 mg FAB 742 (M + H)⁺ 209 toluene 5.1 mg FAB 664 (M + H)⁺ 210 DMF 3.2 mg FAB 655 (M + H)⁺ 211 CH₂Cl₂ 22.7 mg FAB 654 (M + H)⁺ 212 DMF 39.8 mg FAB 709 (M + H)⁺ 213 DMF 18.2 mg FAB 638 (M + H)⁺ 214 DMF 14.9 mg FAB 652 (M + H)⁺ 215 DMF 5.6 mg FAB 624 (M + H)⁺ 216 DMF 8.2 mg FAB 675 (M + H)⁺ 217 DMF 40.6 mg FAB 675 (M + H)⁺ 219 DMF 38.9 mg FAB 704 (M + H)⁺ 220 DMF 37.9 mg FAB 770 (M + H)⁺ 221 DMF 35.4 mg FAB 743 (M + H)⁺ 223 DMF 10.4 mg FAB 788 (M + H)⁺ 224 DMF 8.0 mg FAB 680 (M + H)⁺

TABLE 16 Compound Starting material No. (Compound No.) Amount Reaction reagent 1 Amount Reaction reagent 2 227 73 20 mg 3-fluoro-isonicotinic acid 15 mg EDCI 14 mg, DMAP 4 mg 228 73 20 mg 3-chloro-isonicotinic acid 17 mg EDCI 14 mg, DMAP 4 mg 229 73 20 mg 3-methylpicolinic acid 14 mg EDCI 28 mg, DMAP 8 mg 230 73 20 mg 3-benzoyl-2-pyridine 48 mg EDCI 28 mg, DMAP 8 mg carboxylic acid 231 73 20 mg 3-n-propoxy picolinic acid 38 mg EDCI 28 mg, DMAP 8 mg 232 73 20 mg 6-fluoro nicotinic acid 30 mg EDCI 28 mg, DMAP 8 mg 233 102 20 mg cyclopentane carboxylic acid 99 mg EDCI 84 mg, DMAP 5 mg 234 102 20 mg cyclohexane carboxylic acid 112 mg EDCI 84 mg, DMAP 5 mg 235 102 20 mg cyano acetic acid 74 mg EDCI 84 mg, DMAP 5 mg 236 102 20 mg cyclopropylacetic acid 87 mg EDCI 84 mg, DMAP 5 mg 237 102 20 mg cyclopropylacetic acid 87 mg EDCI 84 mg, DMAP 5 mg 238 102 20 mg 2,2-difluoro-1-methylcyclo- 118 mg EDCI 84 mg, DMAP 5 mg propanecarboxylic acid 239 73 20 mg 4-methylnicotinic acid 36 mg EDCI 28 mg, DMAP 8 mg 240 73 20 mg 4-chloro nicotinic acid 33 mg EDCI 28 mg, DMAP 8 mg 241 73 20 mg (4-methoxy carbonyl) nicotinic acid 38 mg EDCI 28 mg, DMAP 8 mg 242 73 20 mg 5-(trifluoromethyl)thieno[3,2- 38 mg EDCI 28 mg, DMAP 8 mg b]pyridine-6-carboxylic acid 243 73 20 mg 2-cyano benzoic acid 31 mg EDCI 28 mg, DMAP 8 mg 244 73 20 mg 2-(trifluoromethyl)benzoic acid 40 mg EDCI 28 mg, DMAP 8 mg 245 73 20 mg 2-fluoro benzoic acid 29 mg EDCI 28 mg, DMAP 8 mg 246 73 20 mg 2-nitro benzoic acid 35 mg EDCI 28 mg, DMAP 8 mg 247 73 20 mg 2-chloro nicotinic acid 33 mg EDCI 28 mg, DMAP 8 mg Compound Mass spectrometric data No. Solvent Yield Measuring Method Data 227 DMF 5.4 mg FAB 693 (M + H)⁺ 228 DMF 7.8 mg FAB 709 (M + H)⁺ 229 DMF 16.7 mg FAB 689 (M + H)⁺ 230 DMF 16.4 mg FAB 779 (M + H)⁺ 231 DMF 17.3 mg FAB 733 (M + H)⁺ 232 DMF 5.3 mg FAB 693 (M + H)⁺ 233 DMF 28.3 mg FAB 746 (M + H)⁺ 234 DMF 21.5 mg FAB 788 (M + H)⁺ 235 DMF 3.3 mg FAB 659 (M + H)⁺ 236 DMF 16.7 mg FAB 786 (M + H)⁺ 237 DMF 8.2 mg FAB 704 (M + H)⁺ 238 DMF 6.1 mg FAB 812 (M + H)⁺ 239 DMF 16.1 mg FAB 689 (M + H)⁺ 240 DMF 13.8 mg FAB 709 (M + H)⁺ 241 DMF 18.8 mg FAB 733 (M + H)⁺ 242 DMF 20.3 mg FAB 799 (M + H)⁺ 243 DMF 6.6 mg FAB 699 (M + H)⁺ 244 DMF 10.2 mg FAB 742 (M + H)⁺ 245 DMF 16.1 mg FAB 692 (M + H)⁺ 246 DMF 9.8 mg FAB 719 (M + H)⁺ 247 DMF 13.1 mg FAB 709 (M + H)⁺

TABLE 17 Compound Starting material No. (Compound No.) Amount Reaction reagent 1 Amount Reaction reagent 2 248 73 20 mg 2-chloro-6-methylnicotinic acid 36 mg EDCI 28 mg, DMAP 8 mg 249 73 20 mg methoxymethyl bromide 31 mg [(CH₃)₂CH]₂NEt 18 mg 250 102 20 mg 2,2-difluorocyclopropane carboxylic acid 106 mg EDCI 84 mg, DMAP 5 mg 251 73 20 mg 3-tert-buthylthio-2-carboxy piridine 44 mg EDCI 28 mg, DMAP 8 mg 252 73 20 mg 3,5-difluoropyridine-2-carboxylic acid 33 mg EDCI 28 mg, DMAP 8 mg 253 73 20 mg pyrazine carboxylic acid 26 mg EDCI 28 mg, DMAP 8 mg 254 73 20 mg 4-thiazole carboxylic acid 27 mg EDCI 28 mg, DMAP 8 mg 255 73 20 mg 3-chloro thiophene-2-carboxylic acid 34 mg EDCI 28 mg, DMAP 8 mg 256 73 20 mg 6-methylnicotinic acid 29 mg EDCI 28 mg, DMAP 8 mg 257 73 20 mg 6-chloro pyridine-2-carboxylic acid 33 mg EDCI 28 mg, DMAP 8 mg 258 73 20 mg 6-fluoro pyridine-2-carboxylic acid 30 mg EDCI 28 mg, DMAP 8 mg 259 73 20 mg 1-methyl indole-2-carboxylic acid 37 mg EDCI 28 mg, DMAP 8 mg 260 73 20 mg 3-chloropyridine-2-carboxylic acid 33 mg EDCI 28 mg, DMAP 8 mg 262 73 20 mg 2-fluoro nicotinic acid 30 mg EDCI 28 mg, DMAP 8 mg 263 73 20 mg 4-cyano benzoic acid 31 mg EDCI 28 mg, DMAP 8 mg 264 73 20 mg 3-cyano benzoic acid 31 mg EDCI 28 mg, DMAP 8 mg 265 73 20 mg 3-(trifluoromethyl)benzoic acid 40 mg EDCI 28 mg, DMAP 8 mg 266 73 20 mg 2-pyridylacetic acid 36 mg EDCI 28 mg, DMAP 8 mg 267 73 20 mg 3-pyridylacetic acid 36 mg EDCI 28 mg, DMAP 8 mg 268 73 20 mg (4-pyridylthio) acetic acid 36 mg EDCI 28 mg, DMAP 4 mg 270 261 20 mg 4-(trifluoromethyl)nicotinic acid 39 mg EDCI 26 mg, DMAP 4 mg 271 261 20 mg 3-chloropyridine-2-carboxylic acid 32 mg EDCI 26 mg, DMAP 4 mg Compound Mass spectrometric data No. Solvent Yield Measuring Method Data 248 DMF 17.2 mg FAB 723 (M + H)⁺ 249 DMF 1.2 mg ESI 614 (M + H)⁺ 250 DMF 23.2 mg ESI 770 (M + H)⁺ 251 DMF 7.6 mg ESI 763 (M + H)⁺ 252 DMF 10.9 mg ESI 711 (M + H)⁺ 253 DMF 10.9 mg ESI 676 (M + H)⁺ 254 DMF 18.5 mg ESI 681 (M + H)⁺ 255 DMF 15.8 mg ESI 714 (M + H)⁺ 256 DMF 15.1 mg ESI 689 (M + H)⁺ 257 DMF 12.7 mg ESI 709 (M + H)⁺ 258 DMF 14.4 mg ESI 693 (M + H)⁺ 259 DMF 18.8 mg ESI 727 (M + H)⁺ 260 DMF 14.6 mg ESI 709 (M + H)⁺ 262 DMF 9.9 mg ESI 693 (M + H)⁺ 263 DMF 14.0 mg ESI 699 (M + H)⁺ 264 DMF 16.9 mg ESI 699 (M + H)⁺ 265 DMF 14.3 mg ESI 742 (M + H)⁺ 266 DMF 11.7 mg ESI 689 (M + H)⁺ 267 DMF 8.6 mg ESI 689 (M + H)⁺ 268 DMF 16.5 mg ESI 721 (M + H)⁺ 270 DMF 8.3 mg ESI 767 (M + H)⁺ 271 DMF 14.5 mg ESI 733 (M + H)⁺

TABLE 18 Compound No. ¹H-NMR δ (ppm) 73 0.91 (3H, s), 1.13 (3H, t, J = 5.1 Hz), 1.14 (3H, t, J = 5.1 Hz), 1.26 (1H, s), 1.32-1.40 (1H, m), 1.42 (3H, s), 1.45 (1H, d, J = 2.7 Hz), 1.49-1.51 (2H, m), 1.66 (3H, s), 1.81-1.91 (2H, m), 2.13-2.18 (1H, m), 2.24-2.37 (4H, m), 2.90 (1H, m), 3.79 (3H, m), 4.80 (1H, dd, J = 3.5, 7.6 Hz), 4.99-5.00 (1H, m), 6.52 (1H, s), 7.42 (1H, dd, J = 3.5, 5.4 Hz), 8.11 (1H, dt, J = 1.4, 5.4 Hz), 8.70 (1H, d, J = 2.4 Hz), 9.00 (1H, s) 77 0.92 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.37-1.46 (1H, m), 1.51 (3H, s), 1.62 (1H, d, J = 3.8 Hz), 1.68-1.82 (2H, m), 1.87 (3H, s), 1.91-2.00 (2H, m), 2.18-2.23 (1H, m), 2.33 (2H, q, J = 7.6 Hz), 2.43 (2H, dq, J = 1.4, 7.6 Hz), 2.97 (1H, s), 3.70 (1H, d, J = 11.9 Hz), 3.84 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 5.1, 11.1 Hz), 5.05 (1H, d, J = 4.3 Hz), 5.27 (1H, dd, J = 4.6, 11.1 Hz), 6.45 (1H, s), 7.39-7.66 (4H, m), 8.05- 8.13 (3H, m), 8.70 (1H, d, J = 4.6 Hz), 9.00 (1H, s) 74 0.90 (3H, s), 1.12 (3H, t, J = 7.8 Hz), 1.13 (3H, t, J = 7.8 Hz), 1.19 (1H, s), 1.25-1.34 (1H, m), 1.44 (3H, s), 1.53-1.63 (3H, m), 1.69 (3H, s), 1.73-1.90 (2H, m), 2.10 (1H, m), 2.16 (3H, s), 2.33 (2H, dq, J = 24, 7.6 Hz), 2.36 (2H, dq, J = 3.2, 7.6 Hz), 2.87 (1H, m), 3.72 (2H, m), 4.81 (1H, dd, J = 4.6, 11.6 Hz), 4.97-5.00 (2H, m), 6.46 (1H, s), 7.40 (1H, dd, J = 4.6, 8.1 Hz), 8.10 (1H, m), 8.69 (1H, d, J = 4.9 Hz), 9.00 (1H, s) 205 0.92 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.42-1.50 (1H, m), 1.59 (3H, s), 1.61-1.83 (3H, m), 1.85 (3H, s), 1.83-2.00 (2H, m), 2.18-2.23 (1H, m), 2.33 (2H, q, J = 7.6 Hz), 2.43 (2H, q, J = 7.6 Hz), 2.94 (1H, m), 3.72 (1H, d, J = 11.9 Hz), 3.82 (1H, d, J = 12.7 Hz), 4.83 (1H, dd, J = 4.9, 11.3 Hz), 5.03-5.06 (1H, m), 5.27 (1H, dd, J = 4.9, 11.3 Hz), 6.42 (1H, s), 7.38 (1H, dd, J = 4.9, 8.1 Hz), 7.45 (1H, dd, J = 4.9, 8.1 Hz), 8.07 (1H, dt, J = 2.2, 8.1 Hz), 8.36 (1H, dt, J = 1.9, 8.1 Hz), 8.67 (1H, dd, J = 1.9, 5.1 Hz), 8.83 (1H, dd, J = 1.9, 4.9 Hz), 8.97 (1H, d, J = 1.9 Hz), 9.30 (1H, d, J = 1.9 Hz) 206 0.90 (3H, s), 1.13 (6H, t, J = 7.6 Hz), 1.19 (1H, s), 1.24 (3H, d, J = 4.6 Hz), 1.26 (3H, d, J = 4.6 Hz), 1.33-1.38 (1H, m), 1.45 (3H, s), 1.54 (1H, d, J = 3.8 Hz), 1.60-1.64 (2H, m), 1.67 (3H, s), 1.75-1.90 (2H, m), 2.15-2.19 (1H, m), 2.32 (2H, q, J = 7.6 Hz), 2.38 (2H, q, J = 7.6 Hz), 2.65 (1H, quint, J = 7.6 Hz), 2.88 (1H, d, J = 1.6 Hz), 3.68 (1H, d, J = 12.4 Hz), 3.83 (1H, d, J = 11.9 Hz), 4.80 (1H, dd, J = 4.9, 11.3 Hz), 5.00 (2H, m), 6.38 (1H, s), 7.40 (1H, dd, J = 4.6, 8.1 Hz), 8.09, (1H, dt, J = 1.9, 8.1 Hz), 8.69 (1H, dd, J = 1.6, 4.6 Hz), 9.00 (1H, d, J = 1.6 Hz)

TABLE 19

¹H-NMR δ (ppm) 208 0.92 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.21 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.39-1.47 (1H, m), 1.50 (3H, s), 1.61 (1H, m), 1.68-1.83 (2H, m), 1.86 3H, s), 1.91-2.05 (2H, m), 2.18-2.23 (1H, m), 2.33 (2H, q, J = 7.6 Hz), 2.43 (2H, dq, J = 1.4, 7.6 Hz), 2.95 (1H, d, J = 2.4 Hz), 3.72 (1H, d, J = 11.9 Hz), 3.82 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 5.1, 11.1 Hz), 5.03-5.06 (1H, m), 5.26 (1H, dd, J = 4.9, 11.1 Hz), 6.40 (1H, s), 7.38 (1H, dd, J - 4.9, 8.4 Hz), 7.76 (2H, d, J = 8.4 Hz), 8.06 (1H, dt, J = 2.2, 8.1 Hz), 8.22 (2H, d, J = 8.4 Hz), 8.66 (1H, dd, J = 1.6, 4.9 Hz), 8.96 (1H, d, J = 2.2 Hz) 211 0.90 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.15 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.29-1.38 (1H, m), 1.41 (3H, s), 1.43-1.71 (5H, m), 1.59 (3H, s), 1.75-1.89 (6H, m), 2.12-2.17 (1H, m), 2.26-2.38 (4H, m), 2.86 (1H, m), 3.45-4.00 (5H, m), 4.82 (1H, dd, J = 5.4, 10.8 Hz), 4.97-5.03 (2H, m), 6.41 (1H, s), 7.40 (1H, dd, J = 4.9, 7.8 Hz), 8.07-8.13 (1H, m), 8.67-8.70 (1H, m), 9.01 (1H, d, J = 2.4 Hz) 212 0.92 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.38-1.46 (1H, m), 1.50 (3H, s), 1.61 (1H, m), 1.66-1.78 (2H, m), 1.84 (3H, s), 1.87-1.99 (2H, m), 2.12-2.23 (1H, m), 2.31 (2H, q. J = 7.6 Hz), 2.41 (2H, q, J = 7.6 Hz), 2.95 (1H, m), 3.73 (1H, d, J = 11.9 Hz), 3.81 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 4.9, 11.3 Hz), 5.04 (1H, m), 5.25 (1H, dd, J = 4.9, 11.3 Hz), 6.40 (1H, s), 7.38 (1H, dd, J = 4.6, 7.8 Hz), 7.47 (1H, d, J = 8.1 Hz), 8.06 (1H, dt, J = 1.6, 7.8 Hz), 8.30 (1H, dd, J = 2.4, 8.1 Hz), 8.67 (1H, dd, J = 1.4, 4.6 Hz), 8.97 (1H, d, J = 2.4 Hz), 9.06 (1H, d, J = 2.7 Hz) 213 0.90 (3H, s), 0.93 (2H, d, J = 2.7 Hz), 0.96 (2H, d, J = 2.7 Hz), 1.03-1.19 (6H, m), 1.26 (1H, s), 1.32-1.39 (1H, m), 1.45 (3H, s), 1.52 (1H, d, J = 3.8 Hz), 1.61-1.69 (3H, m), 1.71 (3H, s), 1.73-1.94 (2H, m), 2.14-2.19 (1H, m), 2.24-2.40 (4H, m), 2.95 (1H, m), 3.68 (1H, d, J = 11.9 Hz), 3.81 (1H, d, J = 11.9 Hz), 4.79 (1H, dd, J = 5.4, 11.3 Hz), 4.96-5.00 (2H, m), 6.45 (1H, s), 7.40 (1H, dd, J = 4.6, 8.1 Hz), 8.10 (1H, dt, J = 1.9, 8.1 Hz), 8.68 (1H, m), 9.01 (1H, m) 214 0.90 (3H, s), 1.13 (3H, t, J = 7.6 Hz), 1.17 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.34-1.40 (1H, m), 1.44 (3H, s), 1.54 (1H, d, J = 4.3 Hz), 1.61 - 1.67 (2H, m), 1.69 (3H, s), 1.72-2.42 (13H, m), 2.91 (1H, m), 3.23 (1H, quint, J = 8.1 Hz), 3.69 (1H, d, J = 11.9 Hz), 3.81 (1H, d, J = 11.9 Hz), 4.80 (1H, dd, J = 4.9, 11.3 Hz), 4.99-5.04 (2H, m), 6.40 (1H, s), 7.39 (1H, dd, J = 4.9, 8.1 Hz), 8.09 (1H, dt, J = 1.6, 8.1 Hz), 8.69 (1H, dd, J = 1.6, 4.6 Hz), 9.01 (1H, d, J = 1.6 Hz) 215 0.90 (3H, s), 1.13 (3H, t, J = 7.6 Hz), 1.17 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.41-1.46 (1H, m), 1.59 (3H, s), 1.65-1.68 (3H, m), 1.73 (3H, s), 1.84-1.90 (2H, m), 2.18 (1H, m), 2.31 (2H, q, J = 7.6 Hz), 2.38 (2H, q, J = 7.6 Hz), 2.93 (1H, m), 3.69 (1H, d, J = 11.9 Hz), 3.81 (1H, d, J = 11.9 Hz), 4.80 (1H, m), 5.01-5.09 (2H, m), 5.92 (1H, dd, J = 1.6, 10.5 Hz), 6.15-6.24 (1H, m), 6.45 (1H, s), 6.45-6.53 (1H, m), 7.40 (1H, dd, J = 4.6, 7.8 Hz), 8.07-8.11 (1H, m), 8.68 (1H, dd, J = 1.9, 4.9 Hz), 9.00 (1H, d, J = 22 Hz)

TABLE 20 Compound No. ¹H-NMR δ (ppm) 216 0.92 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.38-1.42 (1H, m), 1.50 (3H, s), 1.64-1.78 (3H, m), 1.85 (3H, s), 1.88-2.08 (2H, m), 2.17-2.23 (1H, m), 2.33 (2H, q, J = 7.6 Hz), 2.42 (2H, dq, J = 1.1, 7.6 Hz), 2.99 (1H, m), 3.72 (1H, d, J = 12.4 Hz), 3.81 (1H, d, J = 11.5 Hz), 4.83 (1H, dd, J = 4.9, 11.5 Hz), 5.03-6.05 (1H, m), 5.25 (1H, dd, J = 5.4, 11.5 Hz), 6.41 (1H, s), 7.37 (1H, dd, J = 5.2, 8.1 Hz), 7.91 (2H, dd, J = 1.6,4.6 Hz), 8.07 (1H, dt, J = 1.6, 8.1 Hz), 8.67 (1H, dd, J = 1.9, 4.9 Hz), 8.83 (2H, dd, J = 1.6, 4.3 Hz), 8.97 (1H, d, J = 1.6 Hz) 217 0.91 (3H, s), 1.13 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.37-1.46 (1H, m), 1.50 (3H, s), 1.63-1.75 (3H, m), 1.87 (3H, s), 1.83-1.96 (2H, m), 2.13-2.23 (1H, m), 2.32 (2H, q, J = 7.6 Hz), 2.41 (2H, dq, J = 1.4, 7.6 Hz), 2.99 (1H, m), 3.67 (1H, d, J = 11.9 Hz), 3.83 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 5.4, 11.3 Hz), 4.98-5.06 (1H, m), 5.38 (1H, dd, J = 5.4, 10.8 Hz), 6.43 (1H, s), 7.36-7.44 (1H, m), 7.50-7.56 (1H, m), 7.89 (1H, dt, J = 1.6, 7.6 Hz), 8.07 (1H, dt, J = 1.6, 8.1 Hz), 8.18 (1H, d, J = 7.6 Hz), 8.67 (1H, dd, J = 1.6, 4.9 Hz), 8.82-8.84 (1H, m), 8.97 (1H, d, J = 2.4 Hz) 218 0.83-1.12 (12H, m), 0.91 (3H, s), 1.26 (1H, s), 1.33-1.41 (1H, m), 1.45 (3H, s), 1.52-1.69 (6H, m), 1.71 (3H, s), 1.81-1.93 (2H, m), 2.14-2.18 (1H, m), 2.92 (1H, m), 3.72 (1H, d, J = 11.9 Hz), 3.82 (1H, d, J = 11.9 Hz), 4.80 (1H, dd, J = 4.9, 11.4 Hz), 4.99-5.04 (2H, m), 6.46 (1H, s), 7.41 (1H, dd, J = 4.9, 8.3 Hz), 8.10 (1H, dt, J = 1.7, 8.3 Hz), 8.69 (1H, dd, J = 1.5, 4.9 Hz), 9.01 (1H, d, J = 1.4 Hz) 219 0.90 (3H, s), 1.26 (1H, s), 1.32-1.41 (1H, m), 1.44 (3H, s), 1.51-1.63 (3H, m), 1.69 (3H, s), 1.79-2.04 (8H, m), 2.17-2.40 (14H, m), 2.89 (1H, m), 3.08-3.26 (3H, m), 3.67 (1H, d, J = 11.9 Hz), 3.78 (1H, d, J = 11.9 Hz), 4.79 (1H, dd, J = 5.4, 11.1 Hz), 4.97-5.00 (2H, m), 6.41 (1H, s), 7.41 (1H, dd, J = 4.9, 8.1 Hz), 8.09 (1H, dt, J = 1.9, 8.4 Hz), 8.68 (1H, m), 9.00(1H, m) 220 1.17 (3H, s), 1.26 (1H, s), 1.57 (3H, s), 1.65 (1H, m), 1.77- 1.82 (2H, m), 1.88 (3H, s), 1.94-2.05 (3H, m), 2.13-2.31 (1H, m), 2.95 (1H, m), 4.16 (2H, s), 5.06 (1H, dd, J = 2.4, 6.5 Hz), 5.17-5.32 (2H, m), 6.42 (1H, s), 7.34-7.64 (10H, m), 8.01- 8.12 (7H, m), 8.66 (1H, dd, J = 1.6, 5.1 Hz), 8.97 (1H, d, J = 1.9 Hz) 221 0.92 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.21 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.44 (1H, m), 1.50 (3H, s), 1.57-1.62 (1H, m), 1.67-1.80 (2H, m), 1.85 (3H, s), 1.91-1.95 (2H, m), 2.17-2.24 (1H, m), 2.33 (2H, q, J = 7.6 Hz), 2.42 (2H, q, J = 7.6 Hz), 2.92 (1H, m), 3.74 (1H, d, J = 11.9 Hz), 3.81 (1H, dd, J = 11.9 Hz), 4.84 (1H, dd, J = 4.9, 11.1 Hz), 5.04 (1H, m), 5.27 (1H, dd, J = 4.9, 11.1 Hz), 6.40 (1H, s), 7.38 (1H, dd, J = 4.9, 8.1 Hz), 7.84 (1H, d, J = 8.4 Hz), 8.05-8.08 (1H, m), 8.64 (1H, d, J = 8.1 Hz), 8.67 (1H, d, J = 4.6 Hz), 8.96 (1H, d, J = 2.2 Hz), 9.38 (1H, s)

TABLE 21 Compound No. ¹H-NMR δ (ppm) 222 0.94 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.19 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.38-1.47 (1H, m), 1.48 (3H, s), 1.57-1.71 (3H, m), 1.76 (3H, s), 1.83-1.97 (2H, m), 2.10-2.22 (1H, m), 2.33 (2H, q, J = 7.6 Hz), 2.41 (2H, dq, J = 1.6, 7.6 Hz), 2.96 (1H, m), 3.74-3.80 (2H, m), 4.83 (1H, dd, J = 5.7, 11.6 Hz), 5.02- 5.03 (1H, m), 5.28 (1H, dd, J = 5.4, 11.6 Hz), 6.41 (1H, s), 7.40 (1H, dd, J = 5.4, 7.6 Hz), 7.69 (1H, d, J = 5.4 Hz), 8.08 (1H, dt, J = 2.2, 8.1 Hz), 8.69 (1H, dd, J = 1.6, 4.9 Hz), 8.97 (1H, d, J = 4.6 Hz), 9.00 (1H, d, J = 2.4 Hz), 9.16 (1H, s) 223 0.94 (3H, s), 1.26 (1H, s), 1.37 (1H, m), 1.47 (3H, s), 1.48- 1.66 (3H, m), 1.71 (3H, s), 1.75-1.96 (2H, m), 2.17-2.24 (1H, m), 2.96 (1H, m), 3.14-3.35 (6H, m), 3.86 (1H, d, J = 12.2 Hz), 3.93 (1H, d, J = 12.2 Hz), 4.87 (1H, dd, J = 5.7, 10.8 Hz), 4.99-5.08 (2H, m), 6.41 (1H, s), 7.41 (1H, dd, J = 4.6, 8.1 Hz), 8.09 (1H, m), 8.69 (1H, m), 9.02 (1H, m) 224 0.91 (3H, s), 1.13 (3H, t, J = 7.3 Hz), 1.17 (3H, t, J = 7.3 Hz), 1.26 (1H, s), 1.40 (1H, m), 1.45 (3H, s), 1.58-1.63 (3H, m), 1.70 (3H, s), 1.73-1.89 (2H, m), 2.10-2.18 (1H, m), 2.32 (2H, q, J = 7.6 Hz), 2.36 (2H, q, J = 7.6 Hz), 2.96 (1H, m), 3.25 (1H, d, J = 9.7 Hz), 3.32 (1H, d, J = 9.7 Hz), 3.69-3.81 (2H, m), 4.80 (1H, dd, J = 6.4, 11.3 Hz), 5.00-5.08 (2H, m), 6.40 (1H, s), 7.41 (1H, dd, J = 4.9, 8.1 Hz), 8.09 (1H, m), 8.69 (1H, dd, J = 1.4, 5.1 Hz), 9.01 (1H, d, J = 2.4 Hz) 225 0.88 (3H, s), 1.13 (3H, t, J = 7.6 Hz), 1.19 (3H, t, J = 7.5 Hz), 1.22 (3H, t, J = 7.6 Hz), 1.24 (3H, s), 1.26 (1H, m), 1.50-1.56 (1H, m), 1.56 (3H, s), 1.55-1.64 (3H, m), 1.70-1.84 (2H, m), 2.31 (2H, dq, J = 1.2, 7.8 Hz), 2.42 (2H, dq, J = 3.4, 13.6 Hz), 2.44 (2H, dq, J = 2.0, 7.5 Hz), 2.79 (1H, dt, J = 1.4, 5.1 Hz), 3.69 (1H, d, J = 11.9 Hz), 3.79 (1H, d, J = 11.9 Hz), 4.79 (1H, dd, J = 4.9, 11.4 Hz), 5.24 (1H, dd, J = 4.9, 11.4 Hz), 6.45 (1H, s), 7.47 (1H, d, J = 8.5 Hz), 8.12 (1H, dd, J = 2.7, 8.5 Hz), 8.83 (1H, d, J = 2.7 Hz) 226 0.89 (3H, s), 1.13 (3H, t, J = 7.6 Hz), 1.19 (3H, t, J = 7.6 Hz), 1.10-1.24 (3H, m), 1.26 (1H, s), 1.31-1.39 (1H, m), 1.44 (3H, s), 1.53 (1H, d, J = 3.8 Hz), 1.61-1.67 (2H, m), 1.69 (3H, s), 1.72-1.92 (2H, m), 2.08-2.18 (1H, m), 2.31 (2H, dq, J = 2.7, 7.6 Hz), 2.44 (2H, dq, J = 1.6, 7.6 Hz), 2.26-2.64 (2H, m), 2.85 (1H, s), 3.69 (1H, d, J = 11.9 Hz), 3.80 (1H, d, J = 11.9 Hz), 4.80 (1H, dd, J = 5.4, 11.3 Hz), 4.92-5.10 (2H, m), 6.41 (1H, s), 7.44 (1H, d, J = 8.4 Hz), 8.05 (1H, dd, J = 2.4, 8.4 Hz), 8.78 (1H, d, J = 2.4 Hz) 227 0.88 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), 1.23-1.33 (1H, m), 1.43 (1H, m), 1.49 (3H, s), 1.61-1.74 (3H, m), 1.82 (3H, s), 1.87-2.23 (3H, m), 2.33 (2H, q, J = 7.6 Hz), 2.42 (2H, q, J = 7.6 Hz), 2.96 (1H, m), 3.73 (1H, d, J = 12.4 Hz), 3.82 (1H, d, J = 12.4 Hz), 4.83 (1H, dd, J = 5.4, 11.3 Hz), 5.03 (1H, m), 5.26 (1H, dd, J = 5.4, 11.3 Hz), 6.43 (1H, s), 7.39 (1H, dd, J = 4.9, 8.1 Hz), 7.86 (1H, t, J = 5.4 Hz), 8.08 (1H, dt, J = 1.9, 7.8 Hz), 8.60 (1H, d, J = 2.2 Hz), 8.66-8.68 (2H, m), 8.98 (1H, d, J = 2.2 Hz)

TABLE 22 Compound No. ¹H-NMR δ (ppm) 228 0.93 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), (1H, s), 1.32-1.44 (1H, m), 1.49 (3H, s), 1.61 (1H, d, J = 4.1 Hz), 1.67-1.75 (2H, m), 1.81 (3H, s), 1.79-2.05 (2H, m), 2.13-2.22 (1H, m), 2.33 (2H, q, J = 7.6 Hz), 2.42 (2H, dq, J = 1.4, 7.6 Hz), 2.92 (1H, m), 3.74 (1H, d, J = 11.9 Hz), 3.82 (1H, d, J = 11.9 Hz), 4.84 (1H, dd, J = 5.4, 10.8 Hz), 5.04 (1H, m), 5.27 (1H, dd, J = 5.4, 10.8 Hz), 6.43 (1H, s), 7.40 (1H, dd, J = 4.9, 8.1 Hz), 7.74 (1H, d, J = 5.1 Hz), 8.08 (1H, dt, J = 2.2, 8.1 Hz), 8.65 (1H, d, J = 4.9 Hz), 8.69 (1H, dd, J = 4.1, 7.6 Hz), 8.78 (1H, s), 8.99 (1H, d, J = 1.9 Hz) 229 0.92 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.19 (3H, t, J = 6.5 Hz), 1.26 (1H, s), 1.34-1.45 (1H, m), 1.49 (3H, s), 1.62 (1H, m), 1.71-1.77 (2H, m), 1.83 (3H, s), 1.88-2.01 (2H, m), 2.14-2.22 (1H, m), 2.33 (2H, q, J = 7.6 Hz), 2.42 (2H, dq, J = 2.2, 7.6 Hz), 2.64 (3H, s), 2.96 (1H, m), 3.72 (1H, d, J = 11.9 Hz), 3.84 (1H, d, J = 11.9 Hz), 4.84 (1H, dd, J = 5.4, 11.3 Hz), 5.04 (1H, m), 5.36 (1H, dd, J = 5.4, 10.8 Hz), 6.42 (1H, s), 7.35-7.42 (2H, m), 7.66 (1H, d, J = 7.8 Hz), 8.08 (1H, dt, J = 1.9, 7.8 Hz), 8.60 (1H, d, J = 4.1 Hz), 8.68 (1H, dd, J = 1.6, 4.9 Hz), 8.98 (1H, d, J = 2.4 Hz), 230 0.78 (3H, s), 1.09 (3H, t, J = 7.8 Hz), 1.12 (3H, t, J = 7.8 Hz), 1.26 (1H, s), 1.33 (3H, s), 1.36-1.38 (1H, m), 1.40-1.48 (2H, m), 1.55 (3H, s), 1.59-1.85 (2H, m), 2.09-2.18 (1H, m), 2.32 (4H, q, J = 7.6 Hz), 2.96 (1H, m), 3.40 (1H, d, J = 11.9 Hz), 3.75 (1H, d, J = 11.9 Hz), 4.72 (1H, dd, J = 4.9, 11.3 Hz), 4.95 (1H, m), 5.17 (1H, dd, J = 5.4, 11.9 Hz), 6.45 (1H, s), 7.40 (1H, dd, J = 4.9, 8.1 Hz), 7.49-7.67 (3H, m), 7.83-7.88 (3H, m), 8.02 (1H, s), 8.07 (1H, dt, J = 2.2, 8.1 Hz), 8.68 (1H, dd, J = 1.4, 4.6 Hz), 8.95 (1H, dd, J = 1.6, 4.6 Hz), 8.99 (1H, d, J = 1.9 Hz) 231 0.91 (3H, s), 1.09 (3H, t, J = 7.6 Hz), 1.14 (3H, t, J = 7.6 Hz), 1.18 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.34-1.43 (1H, m), 1.48 (3H, s), 1.63 (1H, m), 1.67-1.75 (2H, m), 1.80 (3H, s), 1.83- 2.08 (4H, m), 2.17-2.25 (1H, m), 2.32 (2H, q, J = 7.6 Hz), 2.40 (2H, dq, J = 7.6, 1.9 Hz), 2.96 (1H, m), 3.64 (1H, d, J = 11.9 Hz), 3.87 (1H, d, J = 11.9 Hz), 4.05 (2H, t, J = 6.2 Hz), 4.82 (1H, dd, J = 5.4, 10.8 Hz), 5.04 (1H, m), 5.40 (1H, dd, J = 5.4, 10.8 Hz), 6.47 (1H, s), 7.19-7.44 (3H, m), 8.08 (1H, dt, J = 1.9, 8.1 Hz), 8.32 (1H, dd, J = 1.6, 4.3 Hz), 8.68 (1H, dd, J = 4.6, 1.6 Hz), 8.98 (1H, d, J = 1.6 Hz) 232 0.92 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.34-1.43 (1H, m), 1.50 (3H, s), 1.61 (1H, m), 1.67-1.78 (2H, m), 1.84 (3H, s), 1.87-1.97 (2H, m), 2.13-2.23 (1H, m), 2.18 (1H, s), 2.32 (2H, q, J = 7.6 Hz), 2.42 (2H, dq, J = 1.4, 7.6 Hz), 3.73 (1H, d, J = 11.9 Hz), 3.80 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 5.4, 11.1 Hz), 5.04 (1H, d, J = 3.8 Hz), 5.25 (1H, dd, J = 5.1, 11.1 Hz), 6.41 (1H, s), 7.06 (1H, dd, J = 3.0, 8.6 Hz), 7.38 (1H, dd, J = 4.9, 8.1 Hz), 8.08 (1H, dt, J = 1.9, 8.1 Hz), 8.43-8.50 (1H, m), 8.67 (1H, dd, J = 1.6, 4.6 Hz), 8.95-8.98 (2H, m)

TABLE 23 Compound No. ¹H-NMR δ (ppm) 233 0.91 (3H, s), 1.26 (1H, s), 1.45 (3H, s), 1.70 (3H, s), 1.32-1.97 (29H, m), 2.14-2.19 (1H, m), 2.66-2.90 (3H, m), 3.06 (1H, s), 3.67 (1H, d, J = 11.9 Hz), 3.78 (1H, d, J = 11.9 Hz), 4.78 (1H, dd, J = 5.4, 10.8 Hz), 4.98-5.01 (2H, m), 6.40 (1H, s), 7.42 (1H, dd, J = 4.9, 8.1 Hz), 8.11 (1H, dt, J = 1.6, 8.1 Hz), 8.69 (1H, d, J = 4.6 Hz), 9.01 (1H, s) 234 0.91 (3H, s), 1.45 (3H, s), 1.70 (3H, s), 1.10-2.05 (37H, m), 2.14-2.49 (3H, m), 3.04 (1H, s), 3.65 (1H, d, J = 11.3 Hz), 3.77 (1H, d, J = 11.9 Hz), 4.78 (1H, dd, J = 5.4, 10.8 Hz), 4.97-5.01 (2H, m), 6.41 (1H, s), 7.42 (1H, dd, J = 4.9, 8.1 Hz), 8.11 (1H, dd, J = 1.9, 8.1 Hz), 8.69 (1H, d, J = 4.3 Hz), 9.01 (1H, s) 235 1.00 (3H, s), 1.25-1.33 (3H, m), 1.48 (3H, s), 1.55 (1H, m), 1.71 (1H, m), 1.75 (3H, s), 1.79-1.98 (2H, m), 2.11-2.21 (1H, m), 3.48 (2H, s), 3.54 (2H, s), 3.60 (2H, s), 3.90 (1H, d, J = 11.9 Hz), 3.99 (1H, d, J = 11.9 Hz), 4.86 (1H, m), 4.98 (1H, m), 5.07-5.12 (1H, m), 6.53 (1H, s), 7.53 (1H, dd, J = 4.9, 8.1 Hz), 8.23 (1H, m), 8.30 (1H, m), 8.70 (1H, m), 9.05 (1H, m) 236 0.11-0.27 (3H, m), 0.52-0.65 (8H, m), 0.88 (3H, s), 0.99-1.14 (5H, m), 1.15 (3H, s), 1.25-1.43 (2H, m), 1.61-1.76 (4H, m), 1.72 (3H, s), 2.18-2.54 (9H, m), 3.74 (1H, d, J = 11.9 Hz), 3.83 (1H, d, J = 11.9 Hz), 4.86 (1H, dd, J = 4.6, 11.6 Hz), 5.01-5.12 (2H, m), 6.41 (1H, s), 7.45 (1H, dd, J = 4.9, 7.8 Hz), 8.16 (1H, m), 8.71 (1H, m), 9.02 (1H, s) 237 0.14-0.26 (6H, m), 0.52-0.64 (6H, m), 0.92 (3H, s), 0.97-1.16 (4H, m), 1.26-1.38 (1H, m), 1.45 (3H, s), 1.52 (1H, m), 1.63- 1.70 (2H, m), 1.70 (3H, s), 1.82-1.91 (2H, m), 2.12-2.41 (7H, m), 2.96 (1H, m), 3.74 (1H, d, J = 11.9 Hz), 3.86 (1H, d, J = 11.9 Hz), 4.84 (1H, dd, J = 4.9, 11.3 Hz), 5.00-5.03 (2H, m), 6.43 (1H, s), 7.42 (1H, dd, J = 4.6, 7.8 Hz), 8.11 (1H, m), 8.70 (1H, d, J = 4.3 Hz), 9.01 (1H, s) 238 0.91 (3H, s), 1.26 (1H, s), 1.44 (3H, s), 1.45 (3H, s), 1.46 (3H, s), 1.34-1.53 (7H, m), 1.52 (3H, s), 1.70 (3H, s), 1.81-2.02 (2H, m), 2.15-2.31 (3H, m), 2.96 (1H, s), 3.67 (1H, m), 4.00 (1H, m), 4.85-5.00 (3H, m), 6.46 (1H, s), 7.45 (1H, dd, J = 4.9, 8.1 Hz), 8.13 (1H, m), 8.70 (1H, m), 9.02 (1H, s) 239 0.93 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.33-1.44 (1H, m), 1.50 (3H, s), 1.61 (1H, m), 1.68-1.77 (2H, m), 1.84 (3H, s), 1.91-1.99 (2H, m), 2.17-2.23 (1H, m), 2.32 (2H, q, J = 7.6 Hz), 2.43 (2H, dq, J = 3.0, 7.6 Hz), 2.69 (3H, s), 2.96 (1H, m), 3.75 (1H, d, J = 12.2 Hz), 3.80 (1H, d, J = 12.2 Hz), 4.48 (1H, dd, J = 5.1, 11.1 Hz), 5.04 (1H, d, J = 4.1 Hz), 5.23 (1H, d, J = 5.4, 10.8 Hz), 6.42 (1H, s), 7.24 (1H, d, J = 5.9 Hz), 7.39 (1H, dd, J = 4.9, 8.1 Hz), 8.08 (1H, d, J = 8.4 Hz), 8.61 (1H, d, J = 5.1 Hz), 8.67 (1H, d, J = 3.5 Hz), 8.98 (1H, s), 9.17 (1H, s)

TABLE 24 Compound No. ¹H-NMR δ (ppm) 240 0.93 (3H, s), 1.13 (3H, t, J = 7.9 Hz), 1.19 (3H, t, J = 7.9 Hz), 1.26 (1H, s), 1.39-1.43 (1H, m), 1.49 (3H, s), 1.61 (1H, m), 1.68-1.79 (2H, m), 1.82 (3H, s), 1.88-2.04 (2H, m), 2.17-2.23 (1H, m), 2.32 (2H, q, J = 7.6 Hz), 2.42 (2H, dq, J = 1.9, 7.6 Hz), 2.96 (1H, s), 3.74 (1H, d, J = 11.9 Hz), 3.83 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 1.6, 5.4 Hz), 5.04 (1H, d, J = 4.1 Hz), 5.27 (1H, dd, J = 5.4, 11.6 Hz), 6.43 (1H, s), 7.39 (1H, dd, J = 4.9, 8.1 Hz), 7.47 (1H, d, J = 5.1 Hz), 8.08 (1H, dt, J = 1.9, 8.1 Hz), 8.68 (1H, dd, J = 1.4, 4.6 Hz), 8.64 (1H, d, J = 5.1 Hz), 8.99 (1H, d, J = 1.9 Hz), 9.14 (1H, s) 241 0.93 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.19 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.38-1.43 (1H, m), 1.49 (3H, s), 1.59 (1H, d, J = 4.4 Hz), 1.66-1.73 (2H, m), 1.78 (3H, s), 1.82-2.05 (2H, m), 2.18-2.23 (1H, m), 2.31 (2H, q, J = 7.6 Hz), 2.41 (2H, dq, J = 1.4, 7.6 Hz), 2.96 (1H, s), 3.72 (1H, d, J = 7.6 Hz), 3.81 (1H, d, J = 7.6 Hz), 3.98 (3H, s), 4.84 (1H, dd, J = 5.4, 11.3 Hz), 5.04 (1H, m), 5.24 (1H, dd, J = 4.9, 10.8 Hz), 6.54 (1H, s), 7.39 (1H, dd, J = 4.9, 8.1 Hz), 7.53 (1H, d, J = 4.9 Hz), 8.08 (1H, dt, J = 1.9, 8.1 Hz), 8.68 (1H, d, J = 4.1 Hz), 8.88 (1H, d, J = 4.9 Hz), 9.00 (1H, s), 9.17 (1H, s) 242 0.95 (3H, s), 1.15 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.38-1.44 (1H, m), 1.49 (3H, s), 1.61 (1H, d, J = 4.1 Hz), 1.68-1.72 (2H, m), 1.76 (3H, s), 1.82-2.06 (2H, m), 2.18-2.23 (1H, m), 2.34 (2H, q, J = 7.6 Hz), 2.43 (2H, dq, J = 2.2, 7.6 Hz), 2.96 (1H, s), 3.78 (1H, d, J = 12.2 Hz), 3.83 (1H, d, J = 12.2 Hz), 4.84 (1H, dd, J = 5.4, 11.3 Hz), 5.04 (1H, d, J = 4.1 Hz), 5.2-5.23 (1H, m), 6.40 (1H, s), 7.40 (1H, dd, J = 4.9, 8.1 Hz), 7.76 (1H, d, J = 5.4 Hz), 8.02-8.11 (2H, m), 8.69 (1H, d, J = 4.3 Hz), 8.74 (1H, s), 9.00 (1H, s) 243 0.93 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.39-1.44 (1H, m), 1.50 (3H, s), 1.62 (1H, m), 1.68-1.75 (2H, m), 1.84 (3H, s), 1.93-1.96 (2H, m), 2.14-2.23 (1H, m), 2.33 (2H, q, J = 7.6 Hz), 2.42 (2H, dq, J = 2.4, 7.6 Hz), 2.96 (1H, s), 3.72 (1H, d, J = 11.9 Hz), 3.83 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 1.6, 5.4 Hz), 5.04 (1H, m), 5.36 (1H, dd, J = 4.9, 11.3 Hz), 6.46 (1H, s), 7.38 (1H, dd, J = 5.4, 7.6 Hz), 7.68-7.78 (2H, m), 7.83-7.88 (1H, m), 8.07 (1H, dt, J = 1.9, 8.1 Hz), 8.19-8.23 (1H, m), 8.67 (1H, dd, J = 1.6, 4.9 Hz), 8.98 (1H, d, J = 2.2 Hz) 244 0.93 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.19 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.34-1.43 (1H, m), 1.48 (3H, s), 1.60 (1H, d, J = 4.1 Hz), 1.66-2.02 (4H, m), 1.73 (3H, s), 2.11-2.23 (1H, m), 2.33 (2H, q, J = 7.6 Hz), 2.41 (2H, dq, J = 2.2, 7.6 Hz), 2.90 (1H, s), 3.74 (1H, d, J = 11.0 Hz), 5.83 (1H, d, J = 11.9 Hz), 4.82 (1H, dd, J = 4.9, 11.1 Hz), 5.03 (1H, m), 6.27 (1H, dd, J = 5.1, 11.6 Hz), 6.43 (1H, s), 7.41 (1H, dd, J = 4.9, 8.1 Hz), 7.65-7.70 (2H, m), 7.78-7.86 (2H, m), 8.09 (1H, dt, J = 1.9, 8.1 Hz), 8.69 (1H, d, J = 3.8 Hz), 9.00 (1H, s)

TABLE 25 Compound No. ¹H-NMR δ (ppm) 245 0.92 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.20 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.39-1.46 (1H, m), 1.49 (3H, s), 1.62 (1H, d, J = 4.1 Hz), 1.83 (3H, s), 1.66-2.02 (4H, m), 2.11-2.23 (1H, m), 2.33 (2H, dq, J = 1.2, 7.6 Hz), 2.42 (2H, dq, J = 3.2, 7.6 Hz), 2.96 (1H, m), 3.70 (1H, d, J = 12.0 Hz), 3.85 (1H, d, J = 12.0 Hz), 4.83 (1H, dd, J = 4.9, 11.7 Hz), 5.04 (1H, m), 5.27 (1H, dd, J = 5.1, 11.9 Hz), 6.45 (1H, s), 7.18 (1H, dd, J = 8.5, 10.9 Hz), 7.27 (1H, m), 7.38 (1H, dd, J = 4.8, 8.1 Hz), 7.55-7.61 (1H, m), 8.03 (1H, dt, J = 1.7, 7.3 Hz), 8.08 (1H, dt, J = 1.7, 8.3 Hz), 8.67 (1H, d, J = 3.9 Hz), 8.98 (1H, s) 246 0.93 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.19 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.32-1.42 (1H, m), 1.45 (3H, s), 1.59 (1H, d, J = 3.0 Hz), 1.66 (3H, s), 1.69-1.92 (4H, m), 2.02-2.21 (1H, m), 2.33 (2H, dq, J = 1.1, 5.1 Hz), 2.42 (2H, dq, J = 2.2, 5.1 Hz), 2.96 (1H, m), 3.76 (1H, d, J = 11.9 Hz), 3.84 (1H, d, J = 12.0 Hz), 4.83 (1H, dd, J = 4.9, 11.7 Hz), 5.03 (1H, d, J = 4.2 Hz), 5.19 (1H, dd, J = 5.4, 11.7 Hz), 6.60 (1H, s), 7.42 (1H, dd, J = 4.6, 8.1 Hz), 7.66-7.76 (2H, m), 7.84 (1H, dd, J = 1.5, 7.5 Hz), 7.93 (1H, dd, J = 1.5, 7.8 Hz), 8.11 (1H, dt, J = 2.1, 8.1 Hz), 8.69 (1H, d, J = 4.6 Hz), 9.03 (1H, s) 247 0.93 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.20 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.42-1.46 (1H, m), 1.49 (3H, s), 1.61 (1H, d, J = 3.0 Hz), 1.68-1.79 (2H, m), 1.82 (3H, s), 1.86-2.02 (2H, m), 2.16-2.22 (1H, m), 2.33 (2H, dq, J = 1.1, 5.1 Hz), 2.42 (2H, dq, J = 2.4, 5.1 Hz), 2.96 (1H, m), 3.74 (1H, d, J = 12.0 Hz), 3.82 (1H, d, J = 12.0 Hz), 4.83 (1H, dd, J = 4.9, 11.7 Hz), 5.04 (1H, m), 5.27 (1H, dd, J = 5.1, 11.7 Hz), 6.44 (1H, s), 7.40 (1H, dd, J = 4.6, 7.8 Hz), 7.72 (1H, dd, J = 1.7, 8.3 Hz), 8.08 (1H, dt, J = 2.2, 8.5 Hz), 8.26 (1H, dd, J = 1.9, 7.8 Hz), 8.58 (1H, dd, J = 1.9, 4.9 Hz), 8.68 (1H, d, J = 3.6 Hz), 9.03 (1H, d, J = 1.7 Hz) 248 0.93 (3H, s), 1.16 (3H, t, J = 7.6 Hz), 1.22 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.42-1.46 (1H, m), 1.49 (3H, s), 1.61 (1H, d, J = 3.0 Hz), 1.68-1.78 (2H, m), 1.82 (3H, s), 1.86-2.01 (2H, m), 2.17-2.22 (1H, m), 2.33 (2H, dq, J = 1.1, 5.1 Hz), 2.42 (2H, dq, J = 2.4, 5.1 Hz), 2.62 (3H, s), 2.98 (1H, m), 3.73 (1H, d, J = 12.0 Hz), 3.84 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 4.8, 11.5 Hz), 5.04 (1H, d, J = 3.4 Hz), 5.25 (1H, dd, J = 5.1, 11.4 Hz), 6.44 (1H, s), 7.22 (1H, d, J = 7.8 Hz), 7.40 (1H, dd, J = 4.9, 8.0 Hz), 8.08 (1H, dt, J = 2.2, 8.0 Hz), 8.18 (1H, d, J = 7.8 Hz), 8.69 (1H, d, J = 3.7 Hz), 8.99 (1H, d, J = 1.7 Hz) 249 0.91 (3H, s), 1.14 (3H, t, J = 7.8 Hz), 1.15 (3H, t, J = 7.8 Hz), 1.26 (1H, s), 1.29-1.39 (1H, m), 1.42 (3H, s), 1.45 (1H, m), 1.57-1.64 (2H, m), 1.66 (3H, s), 1.81-1.88 (2H, m), 2.14-2.18 (1H, m), 2.33 (2H, q, J = 7.8 Hz), 2.35 (2H, q, J = 7.8 Hz), 2.84 (1H, m), 3.46 (3H, s), 3.68 (1H, d, J = 11.7 Hz), 3.93 (1H, d, J = 11.9 Hz), 4.73-4.87 (4H, m), 4.95-5.00 (1H, m), 6.43 (1H, s), 7.42 (1H, dd, J = 4.8, 8.0 Hz), 8.12 (1H, m), 8.69 (1H, m), 9.01 (1H, d, J = 2.2 Hz) 250 0.92 (3H, s), 1.26 (1H, s), 1.34-1.55 (3H, m), 1.46 (3H, s), 1.71 (3H, s), 1.66-1.92 (6H, m), 2.01-2.18 (4H, m), 2.38- 2.57 (3H, m), 3.66-3.78 (1H, m), 3.95-4.13 (1H, m), 4.73- 4.84 (1H, m), 4.89-4.95 (1H, m), 4.99-5.10 (1H, m), 6.45 (1H, s), 7.43 (1H, dd, J = 4.9, 8.3 Hz), 8.11 (1H, m), 8.70 (1H, d, J = 4.9 Hz), 9.02 (1H, s)

TABLE 26 Compound No. ¹H-NMR δ (ppm) 251 0.93 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.17 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.36 (9H, s), 1.42 (1H, m), 1.47 (3H, s), 1.62- 1.70 (3H, m), 1.75 (3H, s), 1.80-1.95 (2H, m), 2.07-2.21 (1H, m), 2.32 (2H, dq, J = 1.5, 7.5 Hz), 2.40 (2H, dq, J = 3.9, 7.6 Hz), 2.96 (1H, m), 3.69 (1H, d, J = 11.9 Hz), 3.87 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 4.9, 11.7 Hz), 5.04 (1H, m), 5.36 (1H, dd, J = 5.1, 11.7 Hz), 6.53 (1H, s), 7.39-7.43 (1H, m), 7.98 (1H, dd, J = 1.7, 8.0 Hz), 8.02 (1H, s), 8.10 (1H, dt, J = 1.7, 8.0 Hz), 8.65 (1H, dd, J = 1.5, 4.7 Hz), 8.69 (1H, d, J = 3.7 Hz), 8.99 (1H, s) 252 0.92 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.19 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.42-1.45 (1H, m), 1.49 (3H, s), 1.62-1.73 (3H, m), 1.82 (3H, s), 1.84-2.00 (2H, m), 2.18-2.22 (1H, m), 2.32 (2H, dq, J = 1.5, 7.5 Hz), 2.41 (2H, dq, J = 2.5, 7.5 Hz), 2.96 (1H, m), 3.68 (1H, d, J = 11.9 Hz), 3.85 (1H, d, J = 11.9 Hz), 4.82 (1H, dd, J = 4.9, 11.7 Hz), 5.04 (1H, m), 5.37 (1H, dd, J = 4.8, 11.7 Hz), 6.44 (1H, s), 7.36-7.41 (2H, m), 8.08 (1H, dt, J = 1.7, 8.0 Hz), 8.53 (1H, d, J = 2.0 Hz), 8.68 (1H, dd, J = 0.7, 4.9 Hz), 8.98 (1H, d, J = 2.6 Hz) 253 0.92 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.20 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.40-1.47 (1H, m), 1.51 (3H, s), 1.64 (1H, d, J = 2.4 Hz), 1.73 (2H, m), 1.87 (3H, s), 1.85-2.00 (2H, m), 2.18- 2.23 (1H, m), 2.32 (2H, q, J = 7.6 Hz), 2.42 (2H, dq, J = 1.5, 7.6 Hz), 2.96 (1H, m), 3.71 (1H, d, J = 12.0 Hz), 3.83 (1H, d, J = 11.9 Hz), 4.84 (1H, dd, J = 4.9, 11.7 Hz), 5.05 (1H, m), 5.39 (1H, dd, J = 5.2, 11.6 Hz), 6.42 (1H, s), 7.39 (1H, dd, J = 4.9, 8.1 Hz), 8.02 (1H, s), 8.07 (1H, m), 8.68 (1H, d, J = 4.4 Hz), 8.80-8.83 (1H, m), 8.97 (1H, m), 9.38 (1H, m) 254 0.91 (3H, s), 1.14 (3H, t, J = 7.6 Hz), 1.19 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.39-1.46 (1H, m), 1.49 (3H, s), 1.63 (1H, d, J = 2.7 Hz), 1.70-1.73 (2H, m), 1.85 (3H, s), 1.88-2.01 (2H, m), 2.18-2.22 (1H, m), 2.32 (2H, q, J = 7.5 Hz), 2.41 (2H, dq, J = 2.2, 7.6 Hz), 2.97 (1H, m), 3.68 (1H, d, J = 11.7 Hz), 3.83 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 4.9, 11.7 Hz), 5.04 (1H, m), 5.34 (1H, dd, J = 5.4, 11.5 Hz), 6.44 (1H, s), 7.39 (1H, dd, J = 4.9, 8.0 Hz), 8.07 (1H, dt, J = 1.9, 6.3 Hz), 8.32 (1H, d, J = 2.0 Hz), 8.67 (1H, d, J = 4.1 Hz), 8.92 (1H, d, J = 2.0 Hz), 8.98 (1H, s) 255 0.92 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.19 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.38-1.45 (1H, m), 1.49 (3H, s), 1.60 (1H, d, J = 3.0 Hz), 1.68-1.70 (2H, m), 1.83 (3H, s), 1.75-1.98 (2H, m), 2.17-2.21 (1H, m), 2.33 (2H, dq, J = 1.7, 7.5 Hz), 2.41 (2H, dq, J = 2.2, 7.5 Hz), 2.97 (1H, m), 3.67 (1H, d, J = 12.0 Hz), 3.87 (1H, d, J = 11.9 Hz), 4.81 (1H, dd, J = 4.9, 11.7 Hz), 5.03 (1H, m), 5.23 (1H, dd, J = 5.1, 11.5 Hz), 6.46 (1H, s), 7.07 (1H, d, J = 5.2 Hz), 7.39 (1H, dd, J = 4.9, 8.1 Hz), 7.54 (1H, d, J = 5.3 Hz), 8.08 (1H, dt, J = 2.2, 8.1 Hz), 8.67 (1H, dd, J = 1.4, 4.9 Hz), 8.99 (1H, d, J = 2.2 Hz)

TABLE 27 Compound No. ¹H-NMR δ (ppm) 256 0.92 (3H, s), 1.12 (3H, t, J = 7.8 Hz), 1.16 (3H, t, J = 7.7 Hz), 1.26 (1H, s), 1.39-1.47 (1H, m), 1.50 (3H, s), 1.61 (1H, d, J = 2.4 Hz), 1.69-1.81 (2H, m), 1.85 (3H, s), 1.90-1.99 (2H, m), 2.18-2.21 (1H, m), 2.33 (2H, dq, J = 1.2, 7.7 Hz), 2.41 (2H, dq, J = 2.7, 7.6 Hz), 2.66 (3H, s), 2.96 (1H, m), 3.72 (1H, d, J = 11.7 Hz), 3.83 (1H, d, J = 12.0 Hz), 4.83 (1H, dd, J = 4.9, 11.4 Hz), 5.04 (1H, m), 5.25 (1H, dd, J = 5.3, 11.7 Hz), 6.41 (1H, s), 7.30 (1H, d, J = 8.0 Hz), 7.38 (1H, dd, J = 4.9, 8.1 Hz), 8.07 (1H, dt, J = 22, 8.1 Hz), 8.24 (1H, dd, J = 2.2, 8.0 Hz), 8.67 (1H, dd, J = 1.5, 4.9 Hz), 8.97 (1H, d, J = 2.2 Hz), 9.18 (1H, d, J = 2.2 Hz) 257 0.91 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.19 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.38-1.46 (1H, m), 1.50 (3H, s), 1.63 (1H, d, J = 2.4 Hz), 1.70-1.73 (2H, m), 1.86 (3H, s), 1.83-1.98 (2H, m), 2.18-2.22 (1H, m), 2.32 (2H, dq, J = 1.5, 7.7 Hz), 2.41 (2H, dq, J = 2.2, 7.7 Hz), 2.96 (1H, d, J = 1.9 Hz), 3.68 (1H, d, J = 11.9 Hz), 3.84 (1H, d, J = 12.0 Hz), 4.83 (1H, dd, J = 4.9, 11.7 Hz), 5.05 (1H, m), 5.32 (1H, dd, J = 5.3, 11.7 Hz), 6.43 ((1H, s), 7.39 1H, dd, J = 4.9, 8.0 Hz), 7.56 (1H, d, J = 8.1 Hz), 7.85 (1H, t, J = 7.8 Hz), 8.07 (2H, m), 8.67 (1H, dd, J = 1.7, 4.9 Hz), 8.98 (1H, d, J = 2.0 Hz) 258 0.91 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.19 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.38-1.46 (1H, m), 1.50 (3H, s), 1.62 (1H, d, J = 2.4 Hz), 1.69-1.72 (2H, m), 1.86 (3H, s), 1.80-1.96 (2H, m), 2.18-2.22 (1H, m), 2.32 (2H, q, J = 7.5 Hz), 2.41 (2H, dq, J = 2.2, 7.5 Hz), 2.93 (1H, d, J = 1.9 Hz), 3.68 (1H, d, J = 11.9 Hz), 3.83 (1H, d, J = 12.0 Hz), 4.83 (1H, dd, J = 4.9, 11.4 Hz), 5.04 (1H, m), 5.33 (1H, dd, J = 5.3, 11.5 Hz), 6.42 (1H, s), 7.20 (1H, dd, J = 2.9, 8.0 Hz), 7.38 (1H, dd, J = 4.9, 8.3 Hz), 8.00 (1H, q, J = 7.8 Hz), 8.08 (2H, m), 8.67 (1H, dd, J = 1.4, 4.6 Hz), 8.97 (1H, d, J = 2.2 Hz) 259 0.93 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.21 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.40-1.47 (1H, m), 1.51 (3H, s), 1.61 (1H, d, J = 3.0 Hz), 1.70-1.83 (2H, m), 1.86 (3H, s), 1.92-1.98 (2H, m), 2.17-2.22 (1H, m), 2.32 (2H, q, J = 7.3 Hz), 2.43 (2H, dq, J = 1.4, 5.3 Hz), 2.97 (1H, d, J = 2.0 Hz), 3.74 (1H, d, J = 11.7 Hz), 3.83 (1H, d, J = 11.7 Hz), 4.13 (3H, s), 4.84 (1H, dd, J = 4.9, 11.4 Hz), 5.05 (1H, m), 5.24 (1H, dd, J = 5.3, 11.7 Hz), 6.43 (1H, s), 7.16-7.20 (1H, m), 7.35-7.44 (4H, m), 7.70 (1H, d, J = 8.1 Hz), 8.05 (1H, dt, J = 1.7, 8.3 Hz), 8.66 (1H, dd, J = 1.5, 4.9 Hz), 8.96 (1H, d, J = 2.2 Hz) 260 0.93 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.19 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.40-1.46 (1H, m), 1.48 (3H, s), 1.63 (1H, d, J = 3.0 Hz), 1.71-1.74 (2H, m), 1.80 (3H, s), 1.83-1.95 (1H, m), 2.02-2.06 (1H, m), 2.18-2.22 (1H, m), 2.32 (2H, dq, J = 1.7, 7.6 Hz), 2.41 (2H, dq, J = 3.4, 7.5 Hz), 2.96 (1H, m), 3.70 (1H, d, J = 12.0 Hz), 3.87 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 4.8, 11.5 Hz), 5.05 (1H, m), 5.37 (1H, dd, J = 4.9, 11.7 Hz), 6.46 (1H, s), 7.39-7.45 (2H, m), 7.87 (1H, dd, J = 1.5, 8.3 Hz), 8.08 (1H, dt, J = 1.5, 8.3 Hz), 8.64 (1H, dd, J = 1.2, 4.6 Hz), 8.69 (1H, d, J = 4.9 Hz), 8.97 (1H, d, J = 2.2 Hz) 261 0.85-1.06 (8H, m), 0.92 (3H, s), 1.26 (1H, s), 1.30-1.40 (1H, m), 1.42 (3H, s), 1.45-1.63 (5H, m), 1.67 (3H, s), 1.81-1.92 (2H, m), 2.14-2.25 (2H, m), 2.88 (1H, d, J = 1.4 Hz), 3.75 (1H, d, J = 11.9 Hz), 3.86 (1H, d, J = 11.6 Hz), 3.78-3.82 (1H, m), 4.82 (1H, dd, J = 5.1, 11.4 Hz), 5.00 (1H, m), 6.52 (1H, s), 7.42 (1H, dd, J = 4.9, 8.0 Hz), 8.11 (1H, dt, J = 1.7, (8.0 Hz), 8.69 1H, dd, J = 1.5, 4.9 Hz), 9.01 (1H, d, J = 1.9 Hz)

TABLE 28 Compound No. ¹H-NMR δ (ppm) 262 0.92 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.20 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.39-1.47 (1H, m), 1.49 (3H, s), 1.61 (1H, d, J = 2.7 Hz), 1.66-1.71 (2H, m), 1.84 (3H, s), 1.76-1.99 (2H, m), 2.18-2.22 (1H, m), 2.32 (2H, dq, J = 1.0, 7.5 Hz), 2.42 (2H, dq, J = 2.7, 7.5 Hz), 2.96 (1H, m), 3.73 (1H, d, J = 11.9 Hz), 3.82 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 4.9, 11.7 Hz), 5.04 (1H, m), 5.26 (1H, dd, J = 5.1, 11.7 Hz), 6.44 (1H, s), 7.35-7.41 (2H, m), 8.07 (1H, dt, J = 1.7, 8.0 Hz), 8.44-8.50 (2H, m), 8.67 (1H, d, J = 4.9 Hz), 8.98 (1H, d, J = 1.7 Hz) 263 0.92 (3H, s), 1.12 (3H, t, J = 7.5 Hz), 1.20 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.30-1.47 (1H, m), 1.50 (3H, s), 1.62 (1H, d, J = 2.4 Hz), 1.69-1.71 (2H, m), 1.85 (3H, s), 1.75-1.97 (2H, m), 2.18-2.22 (1H, m), 2.33 (2H, dq, J = 0.9, 7.6 Hz), 2.42 (2H, dq, J = 2.4, 7.6 Hz), 2.98 (1H, m), 3.73 (1H, d, J = 11.6 Hz), 3.81 (1H, d, J = 11.9 Hz), 4.84 (1H, dd, J = 4.9, 11.7 Hz), 5.06 (1H, m), 5.26 (1H, dd, J = 5.1, 11.5 Hz), 6.40 (1H, s), 7.38 (1H, dd, J = 4.9, 8.0 Hz), 7.80 (2H, d, J = 8.8 Hz), 8.06 (1H, dt, J = 1.7, 8.0 Hz), 8.21 (2H, d, J = 8.8 Hz), 8.67 (1H, dd, J = 1.5, 4.9 Hz), 8.96 (1H, d, J = 1.7 Hz) 264 0.92 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.20 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.39-1.47 (1H, m), 1.51 (3H, s), 1.62 (1H, d, J = 2.4 Hz), 1.68-1.82 (2H, m), 1.86 (3H, s), 1.93-2.01 (2H, m), 2.19-2.23 (1H, m), 2.32 (2H, dq, J = 1.0, 7.6 Hz), 2.42 (2H, dq, J = 2.4, 7.5 Hz), 2.97 (1H, m), 3.73 (1H, d, J = 11.9 Hz), 3.80 (1H, d, J = 11.9 Hz), 4.84 (1H, dd, J = 4.9, 11.7 Hz), 5.05 (1H, m), 5.26 (1H, dd, J = 5.1, 11.5 Hz), 6.41 (1H, s), 7.38(1H, dd, J = 4.1, 8.0 Hz), 7.65 (1H, m), 7.90 (1H, dt, J = 1.5, 7.8 Hz), 8.07 (1H, dt, J = 2.2, 8.0 Hz), 8.34 (1H, dt, J = 1.5, 7.8 Hz), 8.38 (1H, t, J = 1.5 Hz), 8.67 (1H, dd, J = 1.5, 4.9 Hz), 8.96 (1H, d, J = 2.4 Hz) 265 0.92 (3H, s), 1.14 (3H, t, J = 7.5 Hz), 1.21 (3H, t, J = 7.5 Hz), 1.26 (1H, s), 1.39-1.48 (1H, m), 1.41 (3H, s), 1.63 (1H, d, J = 2.7 Hz), 1.63-1.83 (2H, m), 1.86 (3H, s), 1.90-1.98 (2H, m), 2.18-2.23 (1H, m), 2.33 (2H, q, J = 7.5 Hz), 2.43 (2H, dq, J = 2.5, 7.6 Hz), 2.97 (1H, m), 3.72 (1H, d, J = 11.9 Hz), 3.82 (1H, d, J = 12.0 Hz), 4.84 (1H, dd, J = 4.9, 11.4 Hz), 5.05 (1H, d, J =4.1 Hz), 5.28 (1H, dd, J = 5.1, 11.5 Hz), 6.42 (1H, s), 7.38 (1H, dd, J = 4.9, 8.0 Hz), 7.65 (1H, t, J = 7.8 Hz), 7.88 (1H, d, J = 7.8 Hz), 8.06 (1H, dt, J = 1.8, 8.0 Hz), 8.30 (1H, d, J = 8.1 Hz), 8.36 (1H, s), 8.67 (1H, dd, J = 1.5, 4.9 Hz), 8.97 (1H, d, J = 2.2 Hz) 266 0.89 (3H, s), 1.13 (3H, t, J = 7.6 Hz), 1.14 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.33-1.37 (1H, m), 1.42 (3H, s), 1.46-1.55 (1H, m), 1.58 (3H, s), 1.60-1.70 (2H, m), 1.78-1.91 (2H, m), 2.13- 2.17 (1H, m), 2.32 (2H, dq, J = 1.7, 7.3 Hz), 2.35 (2H, q, J = 7.3 Hz), 2.89 (1H, m), 3.66 (1H, d, J = 11.4 Hz), 3.81 (1H, d, J = 12.0 Hz), 3.96 (2H, s), 4.76-4.82 (1H, m), 4.98-5.06 (2H, m), 6.38 (1H, s), 7.17-7.25 (1H, m), 7.36-7.46 (2H, m), 7.69- 7.73 (1H, m), 8.08-8.12 (1H, m), 8.60 (1H, dt, J = 1.0, 4.9 Hz), 8.70 (1H, dd, J = 1.7, 4.9 Hz), 9.00 (1H, d, J = 1.4 Hz)

TABLE 29 Compound No. 1H-NMR δ (ppm) 267 0.89 (3H, s), 1.13 (3H, t, J = 7.6 Hz), 1.15 (3H, t, J = 7.6 Hz), 1.26 (1H, s), 1.43 (3H, s), 1.50 (3H, d, J = 3.0 Hz), 1.61 (3H, s), 1.58-1.70 (2H, m), 1.75-1.93 (2H, m), 2.14-2.18 (1H, m), 2.32 (2H, q, J = 7.6 Hz), 2.36 (2H, q, J = 7.6 Hz), 2.90 (1H, d, J = 1.9 Hz), 3.70 (1H, d, J = 12.0 Hz), 3.74 (2H, s), 3.77 (1H, d, J = 11.9 Hz), 4.79 (1H, dd, J = 4.9, 11.4 Hz), 4.96- 5.00 (2H, m), 6.37 (1H, s), 7.32 (1H, dd, J = 4.8, 7.6 Hz), 7.42 (1H, dd, J = 4.9, 8.1 Hz), 7.71 (1H, d, J = 7.8 Hz), 8.12 (1H, dt, J = 1.9, 8.1 Hz), 8.57 (1H, dd, J = 1.6, 4.8 Hz), 8.65 (1H, d, J = 1.9 Hz), 8.70 (1H, dd, J = 1.6, 4.7 Hz), 9.04 (1H, d, J = 4.2 Hz) 269 0.85-1.11 (8H, m), 0.93 (3H, s), 1.26 (1H, s), 1.39-1.47 (1H, m), 1.50 (3H, s), 1.55-1.68 (5H, m), 1.87 (3H, s), 1.83-2.02 (2H, m), 2.17-2.22 (1H, m), 2.96 (1H, s), 3.79 (1H, d, J = 12.2 Hz), 3.83 (1H, d, J = 12.1 Hz), 4.85 (1H, dd, J = 4.9, 11.5 Hz), 5.04 (1H, m), 5.38 (1H, dd, J = 5.12, 11.6 Hz), 6.46 (1H, s), 7.38 (1H, dd, J = 4.8, 8.2 Hz), 7.69-7.80 (2H, m), 7.87 (1H, m), 8.08 (1H, dt, J = 2.2, 8.0 Hz), 8.22 (1H, dd, J = 1.7, 7.5 Hz), 8.67 (1H, dd, J = 1.5, 4.9 Hz), 8.98 (1H, d, J = 2.4 Hz) 270 0.86-1.10 (8H, m), 0.94 (3H, s), 1.26 (1H, s), 1.38-1.46 (1H, m), 1.49 (3H, s), 1.57-1.69 (5H, m), 1.75 (3H, s), 1.78-2.05 (2H, m), 2.18-2.21 (1H, m), 2.93 (1H, m), 3.80 (1H, d, J = 11.9 Hz), 3.84 (1H, d, J = 11.9 Hz), 4.84 (1H, dd, J = 5.0, 11.6 Hz), 5.04 (1H, m), 5.31 (1H, dd, J = 5.0, 11.8 Hz), 6.42 (1H, s), 7.40 (1H, dd, J = 4.9, 8.3 Hz), 7.70 (1H, d, J = 5.3 Hz), 8.09 (1H, dt, J = 1.7, 8.1 Hz), 8.69 (1H, dd, J = 1.6, 4.7 Hz), 8.97 (1H, d, J = 5.1 Hz), 9.00 (1H, d, J = 2.2 Hz), 9.17 (1H, s) 271 0.85-1.08 (8H, m), 0.92 (3H, s), 1.26 (1H, s), 1.38-1.46 (1H, m), 1.48 (3H, s), 1.56-1.68 (5H, m), 1.79 (3H, s), 1.83-2.08 (2H, m), 2.18-2.21 (1H, m), 2.95 (1H, m), 3.76 (1H, d, J = 11.9 Hz), 3.86 (1H, d, J = 11.9 Hz), 4.83 (1H, dd, J = 4.9, 11.5 Hz), 5.04 (1H, m), 5.39 (1H, dd, J = 5.1, 11.9 Hz), 646 (1H, s), 7.34-7.45 (2H, m), 7.86 (1H, dd, J = 1.3, 8.0 Hz), 8.08 (1H, dt, J = 2.0, 8.0 Hz), 8.64 (1H, dd, J = 1.2, 4.7 Hz), 8.68 (1H, dd, J = 1.5, 4.9 Hz), 9.00 (1H, d, J = 2.2 Hz)

Example 11 Preparation Example 1 Wettable Powder

Compound according to the present invention

(Compound No. 82) 30 wt % Clay 30 wt % Diatomaceous earth 35 wt % Calcium lignin sulfonate  4 wt % Sodium laurylsulfate  1 wt % The above ingredients were homogeneously mixed together, and the mixture was ground to prepare wettable powder.

Preparation Example 2 Dust

Compound according to the present invention

(Compound No. 82)  2 wt % Clay 60 wt % Talc 37 wt % Calcium stearate  1 wt % The above ingredients were homogeneously mixed together to prepare dust.

Preparation Example 3 Emulsifiable Concentrate

Compound according to the present invention

(Compound No. 82) 20 wt % N,N-Dimethylformamide 20 wt % Solvesso 150 (Exxon Mobil Corporation) 50 wt % Polyoxyethylene alkylaryl ether 10 wt % The above ingredients were homogeneously mixed and dissolved to prepare emulsifiable concentrate.

Preparation Example 4 Granules

Compound according to the present invention

(Compound No. 28)  5 wt % Bentonite 40 wt % Talc 10 wt % Clay 43 wt % Calcium lignin sulfonate  2 wt % The above ingredients were homogeneously ground and homogeneously mixed together. Water was added to the mixture, followed by thorough kneading. Thereafter, the kneaded product was granulated and dried to prepare granules.

Preparation Example 5 Floables

Compound according to the present invention (Compound No. 28) 25 wt % POE polystyrylphenyl ether sulfate 5 wt % Propylene glycol 6 wt % Bentonite 1 wt % 1% aqueous xanthan gum solution 3 wt % PRONAL EX-300 0.05 wt % (Toho Chemical Industry Co. Ltd.) ADDAC 827 0.02 wt % (K.I. Chemical Industry Co., Ltd.) Water To 100 wt % All the above ingredients except for the 1% aqueous xanthan gum solution and a suitable amount of water were premixed together, and the mixture was then ground by a wet grinding mill. Thereafter, the 1% aqueous xanthan gum solution and the remaining water were added to the ground product to prepare 100 wt % floables.

Test Example 1 Pesticidal Effect Against Myzus persicae

Among the compounds of formula (I) produced by the conventional method described above, the compounds shown in Tables 1 to 14 and pyripyropene A were tested for pesticidal effect.

A leaf disk having a diameter of 2.8 cmφ was cut out from a cabbage grown in a pot and was placed in a 5.0 cm-Schale. Four adult aphids of Myzus persicae were released in the Schale. One day after the release of the adult aphids, the adult aphids were removed. The number of larvae at the first instar born in the leaf disk was adjusted to 10, and a test solution, which had been adjusted to a concentration of 20 ppm by the addition of a 50% aqueous acetone solution (0.05% Tween 20 added) was spread over the cabbage leaf disk. The cabbage leaf disk was then air dried. Thereafter, the Schale was lidded and was allowed to stand in a temperature-controlled room (light period 16 hr-dark period 8 hr) (25° C.). Three days after the initiation of standing of the Schale, the larvae were observed for survival or death, and the death rate of larvae was calculated by the following equation. Death rate (%)={number of dead larvae/(number of survived larvae+number of dead larvae)}×100

As result, it was found that the death rate was not less than 80% for compounds of Nos. 1, 6, 8, 9, 10, 12, 14, 16, 18, 20, 23, 25, 28, 34, 35, 36, 37, 38, 39, 40, 44, 45, 49, 54, 56, 57, 61, 69, 76, 82, 85, 86, 88, 90, 91, 98, 103, 106, 107, 108, 109, 111, 125, 128, 133, 135, 137, 139, 142, 153, 160, 161, 162, 164, 167, 169, 170, 171, 172, 176, 180, 182, 183, 186, 187, 190, 196, 201, 205, 206, 207, 208, 209, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 221, 222, 223, 226, 227, 228, 229, 230, 231, 232, 233, 236, 237, 239, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273, and 274 and pyripyropene A.

Test Example 2 Pesticidal Effect Against Myzus persicae

Among the compounds of formula (I) produced by the conventional method described above, the compounds shown in Tables 1 to 14 and pyripyropene A were tested for pesticidal effect.

A leaf disk having a diameter of 2.8 cmφ was cut out from a cabbage grown in a pot and was placed in a 5.0 cm-Schale. Four adult aphids of Myzus persicae were released in the Schale. One day after the release of the adult aphids, the adult aphids were removed. The number of larvae at the first instar born in the leaf disk was adjusted to 10, and a test solution, which had been adjusted to a concentration of 0.156 ppm by the addition of a 50% aqueous acetone solution (0.05% Tween 20 added) was spread over the cabbage leaf disk. The cabbage leaf disk was then air dried. Thereafter, the Schale was lidded and was allowed to stand in a temperature-controlled room (light period 16 hr-dark period 8 hr) (25° C.). Three days after the initiation of standing, the larvae were observed for survival or death, and the death rate of larvae was calculated in the same manner as in Test Example 1.

As a result, it was found that the death rate was not less than 80% for compounds of Nos. 12, 23, 28, 45, 54, 56, 76, 82, 85, 86, 90, 164, 201, 205, 206, 207, 212, 213, 217, 218, 219, 222, 227, 228, 229, 231, 232, 233, 237, 239, 240, 242, 246, 247, 249, 250, 252, 253, 256, 258, 261, 262, 264, 265, 266, 267, 269, 270, and 271.

Test Example 3 Pesticidal Effect Against Plutella xylostella

A cabbage leaf disk having a diameter of 5 cm was placed in a plastic cup. Test compounds, which had been diluted to a predetermined concentration by the addition of a 50% aqueous acetone solution (Tween 20, 0.05% added), were spread over the cabbage leaf disk by means of a spray gun, and the cabbage leaf disk was then air dried. Five larvae at the second instar of Plutella xylostella were released in the cup. The cup was then lidded, and the larvae were reared in the temperature-controlled room (25° C.). Three days after the treatment, the larvae were observed for survival or death, and the death rate of the larvae was calculated in the same manner as in Test Example 1.

As a result, it was found that the death rate was not less than 80% for compounds of Nos. 76, 213, 218, 237 and 250 at a concentration of 500 ppm.

Test Example 4 Pesticidal Effect Against Helicoverpa armigera

A cabbage leaf disk having a diameter of 2.8 cm was placed in a plastic cup. Test compounds, which had been diluted to a predetermined concentration by the addition of a 50% aqueous acetone solution (Tween 20, 0.05% added), were spread over the cabbage leaf disk by means of a spray gun, and the cabbage leaf disk was then air dried. A larva at the third instar of Helicoverpa armigera was released in the cup. The cup was then lidded, and the larva was reared in the temperature-controlled room (25° C.). Three days after the treatment, the larva was observed for survival or death. The test was repeated 5 times. Further, the death rate of the larvae were calculated in the same manner as in Test Example 1.

As a result, it was found that the death rate was not less than 80% for the compound of No. 219 at a concentration of 100 ppm.

Test Example 5 Pesticidal Effect Against Trigonotylus caelestialium

A wheat seedling was immersed for 30 seconds in a solution, in which each test compound had been diluted to a predetermined concentration by the addition of a 50% aqueous acetone solution (Tween 20, 0.05% added). The wheat seedling was air dried, and then placed in a glass cylinder. Further, two larvae at the second instar of Trigonotylus caelestialium were released in the glass cylinder. The glass cylinder was then lidded, and the larvae were reared in the temperature-controlled room (25° C.). During the test, the wheat seedling was supplied with water from the bottom of the glass cylinder. Three days after the treatment, the larvae were observed for survival or death, and the death rate of the larvae were calculated in the same manner as in Test Example 1.

As a result, it was found that the death rate was not less than 80% for compound of Nos. 218 and 261 at a concentration of 100 ppm. 

The invention claimed is:
 1. A method for controlling a hemipteran pest, comprising applying an effective amount of a compound represented by formula (Ia) or an agriculturally and horticulturally acceptable salt thereof to a plant or soil,

wherein Het₂ represents optionally substituted 3-pyridyl, R₁₁ represents hydroxyl, optionally substituted C₁₋₆ alkylcarbonyloxy, optionally substituted C₂₋₆ alkenylcarbonyloxy, optionally substituted C₂₋₆ alkynylcarbonyloxy, optionally substituted C₁₋₆ alkyloxy, optionally substituted C₂₋₆ alkenyloxy, optionally substituted C₂₋₆ alkynyloxy, optionally substituted benzyloxy, or oxo in the absence of a hydrogen atom at the 13-position, or the bond between 5-position and 13-position represents a double bond in the absence of R₁₁ and a hydrogen atom at the 5-position, R₁₂ represents hydroxyl, optionally substituted C₁₋₁₈ alkylcarbonyloxy, optionally substituted C₂₋₆ alkenylcarbonyloxy, optionally substituted C₂₋₆ alkynylcarbonyloxy, optionally substituted benzoyloxy, or optionally substituted C₁₋₆ alkylsulfonyloxy, R₁₃ represents a hydrogen atom, hydroxyl, optionally substituted C₁₋₁₈ alkylcarbonyloxy, optionally substituted C₂₋₆ alkenylcarbonyloxy, optionally substituted C₂₋₆ alkynylcarbonyloxy, optionally substituted benzoyloxy, optionally substituted C₁₋₆ alkylsulfonyloxy, optionally substituted benzenesulfonyloxy, or optionally substituted five- or six-membered heterocyclic thiocarbonyloxy, or R₁₂ and R₁₃ together represent —O—CR₁₂′R₁₃′—O— wherein R₁₂′ and R₁₃′, which may be the same or different, represent a hydrogen atom, C₁₋₆ alkyl, C₁₋₆ alkyloxy, C₂₋₆ alkenyl, optionally substituted phenyl, or optionally substituted benzyl, or R₁₂′ and R₁₃′ together represent oxo or C₂₋₆ alkylene, and R₁₄ represents a hydrogen atom, hydroxyl, optionally substituted C₁₋₁₈ alkylcarbonyloxy, optionally substituted C₂₋₆ alkenylcarbonyloxy, optionally substituted C₂₋₆ alkynylcarbonyloxy, optionally substituted benzoyloxy, optionally substituted C₁₋₆ alkylsulfonyloxy, optionally substituted benzenesulfonyloxy, optionally substituted benzyloxy, optionally substituted C₁₋₆ alkyloxy, optionally substituted C₂₋₆ alkenyloxy, optionally substituted C₂₋₆ alkynyloxy, C₁₋₆ alkyloxy-C₁₋₆ alkyloxy, C₁₋₆ alkylthio-C₁₋₆ alkyloxy, C₁₋₆ alkyloxy-C₁₋₆ alkyloxy-C₁₋₆ alkyloxy, optionally substituted C₁₋₆ alkyloxycarbonyloxy, optionally substituted C₁₋₆ alkylaminocarbonyloxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic oxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic carbonyloxy, optionally substituted thieno[3,2-b]pyridylcarbonyloxy, optionally substituted 1H-indolylcarbonyloxy, optionally substituted saturated or unsaturated five- or six-membered heterocyclic thiocarbonyloxy, or oxo in the absence of a hydrogen atom at the 7-position. 